View Filing Data

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Sep. 30, 2012	Nov. 05, 2012
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2012
Document Fiscal Year Focus	2012
Document Fiscal Period Focus	Q3
Trading Symbol	MPW
Entity Registrant Name	MEDICAL PROPERTIES TRUST INC
Entity Central Index Key	0001287865
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		135,572,131
MPT Operating Partnership, L.P.
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2012
Document Fiscal Year Focus	2012
Document Fiscal Period Focus	Q3
Entity Registrant Name	MPT Operating Partnership, L.P.
Entity Central Index Key	0001524607
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2012	Dec. 31, 2011
Real estate assets
Land, buildings and improvements, and intangible lease assets	$ 1,251,909	$ 1,217,559
Real estate held for sale	17,432	48,925
Mortgage loans	368,650	165,000
Net investment in direct financing leases	312,050
Gross investment in real estate assets	1,950,041	1,431,484
Accumulated depreciation and amortization	(120,215)	(94,822)
Net investment in real estate assets	1,829,826	1,336,662
Cash and cash equivalents	36,163	102,726
Interest and rent receivable	42,094	29,862
Straight-line rent receivable	38,065	33,993
Other loans	158,177	74,839
Other assets	54,074	43,792
Total Assets	2,158,399	1,621,874
Liabilities
Debt, net	1,025,183	689,849
Accounts payable and accrued expenses	64,297	51,125
Deferred revenue	20,374	23,307
Lease deposits and other obligations to tenants	15,387	28,778
Total liabilities	1,125,241	793,059
Equity/Capital
Preferred stock, $0.001 par value. Authorized 10,000 shares; no shares outstanding
Common stock, $0.001 par value. Authorized 250,000 shares; issued and outstanding - 134,657 shares at September 30, 2012, and 110,786 shares at December 31, 2011	135	111
Additional paid in capital	1,280,769	1,055,256
Distributions in excess of net income	(234,264)	(214,059)
Accumulated other comprehensive loss	(13,220)	(12,231)
Treasury shares, at cost	(262)	(262)
Total equity	1,033,158	828,815
Total Liabilities and Equity	2,158,399	1,621,874
MPT Operating Partnership, L.P.
Real estate assets
Land, buildings and improvements, and intangible lease assets	1,251,909	1,217,559
Real estate held for sale	17,432	48,925
Mortgage loans	368,650	165,000
Net investment in direct financing leases	312,050
Gross investment in real estate assets	1,950,041	1,431,484
Accumulated depreciation and amortization	(120,215)	(94,822)
Net investment in real estate assets	1,829,826	1,336,662
Cash and cash equivalents	36,163	102,726
Interest and rent receivable	42,094	29,862
Straight-line rent receivable	38,065	33,993
Other loans	158,177	74,839
Other assets	54,074	43,792
Total Assets	2,158,399	1,621,874
Liabilities
Debt, net	1,025,183	689,849
Accounts payable and accrued expenses	37,157	28,780
Deferred revenue	20,374	23,307
Lease deposits and other obligations to tenants	15,387	28,778
Payable due to Medical Properties Trust, Inc.	26,750	21,955
Total liabilities	1,124,851	792,669
Equity/Capital
General Partner - issued and outstanding - 1,345 units at September 30, 2012 and 1,107 units at December 31, 2011	10,431	8,418
Accumulated other comprehensive loss	(13,220)	(12,231)
Total capital	1,033,548	829,205
Total Liabilities and Equity	2,158,399	1,621,874
MPT Operating Partnership, L.P. \| Common Stock
Equity/Capital
Limited Partners Capital	1,036,337	833,018
MPT Operating Partnership, L.P. \| Ltip Units
Equity/Capital
Limited Partners Capital

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2012	Dec. 31, 2011
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares outstanding
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	250,000,000	250,000,000
Common stock, shares issued	134,657,000	110,786,000
Common stock, shares outstanding	134,657,000	110,786,000
MPT Operating Partnership, L.P.
Common stock, shares issued	23,575,000
General Partner, units issued	1,345,000	1,107,000
General Partner, units outstanding	1,345,000	1,107,000
MPT Operating Partnership, L.P. \| Common Stock
Limited Partners, units issued	133,312,000	109,679,000
Limited Partners, units outstanding	133,312,000	109,679,000
MPT Operating Partnership, L.P. \| Ltip Units
Limited Partners, units issued	150,000	150,000
Limited Partners, units outstanding	150,000	150,000

Condensed Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Revenues
Rent billed	$ 31,083	$ 27,760	$ 93,100	$ 81,086
Straight-line rent	2,762	1,643	5,473	5,318
Income from direct financing leases	5,773		12,979
Interest and fee income	14,037	5,229	33,486	15,714
Total revenues	53,655	34,632	145,038	102,118
Expenses
Real estate depreciation and amortization	8,491	7,700	25,392	22,508
Property-related	218	260	1,044	346
General and administrative	7,052	5,737	21,341	20,429
Acquisition expenses	410	530	4,115	3,186
Total operating expenses	16,171	14,227	51,892	46,469
Operating income	37,484	20,405	93,146	55,649
Other income (expense)
Interest and other (expense) income	(23)	42	(55)	(12)
Earnings from equity and other interests	1,065	9	1,944	70
Debt refinancing costs		(10,425)		(14,214)
Interest expense	(15,046)	(11,935)	(42,730)	(32,462)
Net other expense	(14,004)	(22,309)	(40,841)	(46,618)
Income (loss) from continuing operations	23,480	(1,904)	52,305	9,031
Income from discontinued operations	8,028	2,372	9,169	4,944
Net income	31,508	468	61,474	13,975
Net income attributable to non-controlling interests	(44)	(43)	(130)	(131)
Net income attributable to MPT common stockholders	$ 31,464	$ 425	$ 61,344	$ 13,844
Earnings per common share - basic and diluted
Income (loss) from continuing operations attributable to MPT common stockholders (Operating Partnership partners)	$ 0.17	$ (0.02)	$ 0.39	$ 0.07
Income from discontinued operations attributable to MPT common stockholders (Operating Partnership partners)	0.06	$ 0.02	0.07	0.05
Net income attributable to MPT common stockholders (Operating Partnership partners)	$ 0.23		$ 0.46	$ 0.12
Weighted average shares (units) outstanding:
Basic	134,781	110,714	131,467	110,568
Diluted	134,782	110,719	131,467	110,576
Dividends declared per common share (unit)	$ 0.20	$ 0.20	$ 0.60	$ 0.60
MPT Operating Partnership, L.P.
Revenues
Rent billed	$ 31,083	$ 27,760	$ 93,100	$ 81,086
Straight-line rent	2,762	1,643	5,473	5,318
Income from direct financing leases	5,773		12,979
Interest and fee income	14,037	5,229	33,486	15,714
Total revenues	53,655	34,632	145,038	102,118
Expenses
Real estate depreciation and amortization	8,491	7,700	25,392	22,508
Property-related	218	260	1,044	346
General and administrative	7,052	5,719	21,341	20,367
Acquisition expenses	410	530	4,115	3,186
Total operating expenses	16,171	14,209	51,892	46,407
Operating income	37,484	20,423	93,146	55,711
Other income (expense)
Interest and other (expense) income	(23)	42	(55)	(12)
Earnings from equity and other interests	1,065	9	1,944	70
Debt refinancing costs		(10,425)		(14,214)
Interest expense	(15,046)	(11,935)	(42,730)	(32,462)
Net other expense	(14,004)	(22,309)	(40,841)	(46,618)
Income (loss) from continuing operations	23,480	(1,886)	52,305	9,093
Income from discontinued operations	8,028	2,372	9,169	4,944
Net income	31,508	486	61,474	14,037
Net income attributable to non-controlling interests	(44)	(43)	(130)	(131)
Net income attributable to MPT common stockholders	$ 31,464	$ 443	$ 61,344	$ 13,906
Earnings per common share - basic and diluted
Income (loss) from continuing operations attributable to MPT common stockholders (Operating Partnership partners)	$ 0.17	$ (0.02)	$ 0.39	$ 0.07
Income from discontinued operations attributable to MPT common stockholders (Operating Partnership partners)	0.06	$ 0.02	0.07	0.05
Net income attributable to MPT common stockholders (Operating Partnership partners)	$ 0.23		$ 0.46	$ 0.12
Weighted average shares (units) outstanding:
Basic	134,781	110,714	131,467	110,568
Diluted	134,782	110,719	131,467	110,576
Dividends declared per common share (unit)	$ 0.20	$ 0.20	$ 0.60	$ 0.60

Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Net income	$ 31,508	$ 468	$ 61,474	$ 13,975
Other comprehensive income (loss):
Unrealized loss on interest rate swap	(443)	(5,272)	(989)	(8,341)
Total comprehensive income (loss)	31,065	(4,804)	60,485	5,634
Comprehensive income attributable to non-controlling interests	(44)	(43)	(130)	(131)
Comprehensive income (loss) attributable to MPT common stockholders (Operating Partnership partners)	31,021	(4,847)	60,355	5,503
MPT Operating Partnership, L.P.
Net income	31,508	486	61,474	14,037
Other comprehensive income (loss):
Unrealized loss on interest rate swap	(443)	(5,272)	(989)	(8,341)
Total comprehensive income (loss)	31,065	(4,786)	60,485	5,696
Comprehensive income attributable to non-controlling interests	(44)	(43)	(130)	(131)
Comprehensive income (loss) attributable to MPT common stockholders (Operating Partnership partners)	$ 31,021	$ (4,829)	$ 60,355	$ 5,565

- Definition

The change in equity [net assets] of a business enterprise during a period from transactions and other events and circumstances from non-owner sources which are attributable to the reporting entity. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners, but excludes any and all transactions which are directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent.

+ References + Details

- Definition

The change in equity [net assets] of a business enterprise during a period from transactions and other events and circumstances from non-owner sources which are attributable to noncontrolling interests. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners, which are directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent.

+ References + Details

- Definition

The change in equity [net assets] of a business enterprise during a period from transactions and other events and circumstances from non-owner sources which are attributable to the economic entity, including both controlling (parent) and noncontrolling interests. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners, including any and all transactions which are directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent.

+ References + Details

- Definition

Net of tax amount, before reclassification adjustments, of the change in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges. Also includes an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 10A
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=20435746&loc=SL7669646-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e637-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6441202&loc=d3e80720-113993

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5624171-113959

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 130
-Paragraph 17, 20
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 130
-Paragraph 121
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 133
-Paragraph 46
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 130
-Paragraph 24
-Subparagraph b
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 38
-Subparagraph c(3)
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

- Definition

The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4569616-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=18733213&loc=SL4591552-111686

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a),(c)
-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=18733213&loc=SL4591551-111686

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 29
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 38
-Subparagraph a
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 38
-Subparagraph c(1)
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 5
-Subparagraph b
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph A1, A4, A5
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011
Operating Activities
Net income	$ 61,474	$ 13,975
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization	26,899	25,254
Straight-line rent revenue (net of write-offs)	(4,100)	(5,606)
Direct financing lease interest accretion	(2,050)
Share-based compensation	5,430	5,293
(Gain) loss on sale of real estate	(7,278)	(5)
Real estate impairment		564
Amortization and write-off of deferred financing costs and debt discount	2,577	8,523
Premium paid on extinguishment of debt		13,091
Other adjustments	(3,415)	(4,632)
Changes in:
Interest and rent receivable	(12,232)	(2,646)
Accounts payable and accrued expenses	7,404	13,317
Net cash provided by operating activities	74,709	67,128
Investing Activities
Cash paid for acquisitions and other related investments	(606,500)	(208,913)
Principal received on loans receivable	9,507	2,898
Net proceeds from sale of real estate	34,100
Investment in loans receivable	(1,293)	(4,398)
Construction in progress and other	(35,920)	(12,297)
Net cash provided by (used in) investing activities	(600,106)	(222,710)
Financing activities
Revolving credit facilities, net	35,400	39,600
Additions to term debt	300,000	450,000
Payments of term debt	(171)	(237,810)
Distributions paid	(76,770)	(67,194)
Sale of common stock, net	220,107
Lease deposits and other obligations to tenants	(13,391)	7,613
Debt issuance costs paid and other financing activities	(6,341)	(20,667)
Net cash provided by financing activities	458,834	171,542
Increase (decrease) in cash and cash equivalents for period	(66,563)	15,960
Cash and cash equivalents at beginning of period	102,726	98,408
Cash and cash equivalents at end of period	36,163	114,368
Interest paid	31,350	18,761
Supplemental schedule of non-cash investing activities:
Loan conversion to equity interest	1,648
Real estate acquired via assumption of mortgage loan		(14,592)
Mortgage loan issued from sale of real estate	3,650
Supplemental schedule of non-cash financing activities:
Distributions declared, unpaid	27,181	22,407
Assumption of mortgage loan (as part of real estate acquired)		14,592
MPT Operating Partnership, L.P.
Operating Activities
Net income	61,474	14,037
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization	26,899	25,254
Straight-line rent revenue (net of write-offs)	(4,100)	(5,606)
Direct financing lease interest accretion	(2,050)
Share-based compensation	5,430	5,293
(Gain) loss on sale of real estate	(7,278)	(5)
Real estate impairment		564
Amortization and write-off of deferred financing costs and debt discount	2,577	8,523
Premium paid on extinguishment of debt		13,091
Other adjustments	(3,415)	(4,694)
Changes in:
Interest and rent receivable	(12,232)	(2,646)
Accounts payable and accrued expenses	7,404	13,317
Net cash provided by operating activities	74,709	67,128
Investing Activities
Cash paid for acquisitions and other related investments	(606,500)	(208,913)
Principal received on loans receivable	9,507	2,898
Net proceeds from sale of real estate	34,100
Investment in loans receivable	(1,293)	(4,398)
Construction in progress and other	(35,920)	(12,297)
Net cash provided by (used in) investing activities	(600,106)	(222,710)
Financing activities
Revolving credit facilities, net	35,400	39,600
Additions to term debt	300,000	450,000
Payments of term debt	(171)	(237,810)
Distributions paid	(76,770)	(67,194)
Sale of common stock, net	220,107
Lease deposits and other obligations to tenants	(13,391)	7,613
Debt issuance costs paid and other financing activities	(6,341)	(20,667)
Net cash provided by financing activities	458,834	171,542
Increase (decrease) in cash and cash equivalents for period	(66,563)	15,960
Cash and cash equivalents at beginning of period	102,726	98,408
Cash and cash equivalents at end of period	36,163	114,368
Interest paid	31,350	18,761
Supplemental schedule of non-cash investing activities:
Loan conversion to equity interest	1,648
Real estate acquired via assumption of mortgage loan		(14,592)
Mortgage loan issued from sale of real estate	3,650
Supplemental schedule of non-cash financing activities:
Distributions declared, unpaid	$ 27,181	22,407
Assumption of mortgage loan (as part of real estate acquired)		$ 14,592

Organization

9 Months Ended

Sep. 30, 2012

Organization

1. Organization

Medical Properties Trust, Inc., a Maryland corporation, was formed on August 27, 2003 under the General Corporation Law of Maryland for the purpose of engaging in the business of investing in, owning, and leasing commercial real estate. Our operating partnership subsidiary, MPT Operating Partnership, L.P., through which we conduct all of our operations, was formed in September 2003. Through another wholly-owned subsidiary, Medical Properties Trust, LLC, we are the sole general partner of the Operating Partnership. At present, we directly own substantially all of the limited partnership interests in the Operating Partnership and have elected to report our required disclosures and that of the Operating Partnership on a combined basis except where material differences exist.

We have operated as a real estate investment trust (“REIT”) since April 6, 2004, and accordingly, elected REIT status upon the filing in September 2005 of the calendar year 2004 federal income tax return. Accordingly, we will not be subject to U.S. federal income tax, provided that we continue to qualify as a REIT and our distributions to our stockholders equal or exceed our taxable income. Certain activities we undertake must be conducted by entities which we elected to be treated as taxable REIT subsidiaries (“TRSs”). Our TRSs are subject to both federal and state income taxes.

Our primary business strategy is to acquire and develop real estate and improvements, primarily for long-term lease to providers of healthcare services such as operators of general acute care hospitals, inpatient physical rehabilitation hospitals, long-term acute care hospitals, surgery centers, centers for treatment of specific conditions such as cardiac, pulmonary, cancer, and neurological hospitals, and other healthcare-oriented facilities. We also make mortgage and other loans to operators of similar facilities. In addition, we may obtain profits or equity interests in our tenants, from time to time, in order to enhance our overall return. We manage our business as a single business segment.

- Definition

The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2134480

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2209116

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2122150

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2197480

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=7880789&loc=SL6228881-111685

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 272
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 720
-SubTopic 15
-URI http://asc.fasb.org/subtopic&trid=2122524

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=7668296&loc=d3e288-107754

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 915
-SubTopic 235
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6472506&loc=d3e38932-110933

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=18733093&loc=d3e5614-111684

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Statement of Position (SOP)
-Number 94-6
-Paragraph 10
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 2-6
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Interpretation (FIN)
-Number 46R
-Paragraph 4, 14, 15
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Staff Position (FSP)
-Number FAS140-4/FIN46(R)-8
-Paragraph 8, C1, C7
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2012

Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

Unaudited Interim Condensed Consolidated Financial Statements: The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information, including rules and regulations of the Securities and Exchange Commission. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine month periods ended September 30, 2012 are not necessarily indicative of the results that may be expected for the year ending December 31, 2012. The condensed consolidated balance sheet at December 31, 2011 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.

For information about significant accounting policies, refer to the consolidated financial statements and footnotes thereto included in our Annual Report on Form 10-K, as amended, for the year ended December 31, 2011. During the three and nine months ended September 30, 2012, there were no material changes to these policies, except we began using direct financing lease (“DFL”) accounting with the acquisition and lease of the real estate of Ernest Health, Inc. (“Ernest”) and the acquisition and lease of two acute care hospitals to Prime Healthcare Services, Inc. (“Prime”). Under DFL accounting, future minimum lease payments are recorded as a receivable. Unearned income, which represents the net investment in the DFL less the sum of minimum lease payments receivable and the estimated residual values of the leased properties, is deferred and amortized to income over the lease term to provide a constant yield when collectability of the lease payments is reasonably assured. Investments in DFLs are presented net of unamortized and unearned income. DFLs are placed on non-accrual status when management determines that the collectability of contractual amounts is not reasonably assured. While on non-accrual status, DFLs are accounted for on a cash basis, in which income is recognized only upon receipt of cash.

For our equity interest in Ernest and related loans (as more fully described in Note 3), we have elected to account for these investments at fair value due to the size of the investments and because we believe this method is more reflective of current values. We have not made a similar election for other equity interests or loans made in or prior to 2012.

Variable Interest Entities

In regard to the Ernest Transaction (defined in Note 3), we have determined that Ernest is a variable interest entity (“VIE”); however, we are not the primary beneficiary as we lack the ability to direct the activities of Ernest that most significantly impact the entity’s economic performance. At September 30, 2012, we had loans to and/or equity investments in several VIEs for which we are not the primary beneficiary. The carrying value and classification of the related assets and maximum exposure to loss as a result of our involvement with these VIEs are presented below at September 30, 2012 (in thousands):


VIE Type	Maximum Loss Exposure(1)		Asset Type Classification	Carrying Amount(2)
Loans, net	$	274,073	Mortgage and other loans	$	230,105
Equity investments	$	13,764	Other assets	$	3,179

(1)

Our maximum loss exposure related to loans with VIEs represents our current aggregate gross carrying value of the loan plus accrued interest and any other related assets (such as rents receivable), less any liabilities. Our maximum loss exposure related to our equity investment in VIEs represents the current carrying values of such investment plus any other related assets (such as rent receivables) less any liabilities.

(2)	Carrying amount reflects the net book value of our loan or equity interest only in the VIE.

For the VIE types above, we do not consolidate the VIE because we do not have the ability to control the activities (such as the day-to-day healthcare operations of our borrowers or investees) that most significantly impact the VIE’s economic performance. As of September 30, 2012, we were not required to provide financial support through a liquidity arrangement or otherwise to our unconsolidated VIEs, including circumstances in which it could be exposed to further losses (e.g., cash short falls).

Typically, our loans are collateralized by assets of the borrower (some assets of which are on the premises of facilities owned by us) and further supported by limited guarantees made by certain principals of the borrower.

See Note 3 for additional description of the nature, purpose and activities of our more significant VIEs and interests therein.

Real Estate and Lending Activities

9 Months Ended

Sep. 30, 2012

Real Estate and Lending Activities

3. Real Estate and Lending Activities

Acquisitions

2012 Activity

On September 19, 2012, we acquired the real estate of the 380 bed St. Mary’s Regional Medical Center, an acute care hospital in Reno, Nevada for $80 million and the real estate of the 140 bed Roxborough Memorial Hospital in Pennsylvania for $30 million. The acquired facilities are leased to Prime pursuant to a master lease agreement, which is more fully described below in the Leasing Operations section.

On July 3, 2012, we funded a $100 million mortgage loan secured by the real property of Centinela Hospital Medical Center. Centinela is a 369 bed acute care facility that is operated by Prime. This mortgage loan is cross-defaulted with other mortgage loans to Prime and the master lease agreements.

On February 29, 2012, we made loans to and acquired assets from Ernest for a combined purchase price and investment of $396.5 million, consisting of $200 million to purchase real estate assets, a first mortgage loan of $100 million, an acquisition loan for $93.2 million and a capital contribution of $3.3 million (“Ernest Transaction”).

Real Estate Acquisition and Mortgage Loan Financing

Pursuant to a definitive real property asset purchase agreement (the “Purchase Agreement”), we acquired from Ernest and certain of its subsidiaries (i) a portfolio of five rehabilitation facilities (including a ground lease interest relating to a community-based acute rehabilitation facility in Wyoming), (ii) seven long-term acute care facilities located in seven states and (iii) undeveloped land in Provo, Utah (collectively, the “Acquired Facilities”) for an aggregate purchase price of $200 million, subject to certain adjustments. The Acquired Facilities are leased to subsidiaries of Ernest pursuant to a master lease agreement. The master lease agreement has a 20-year term with three five-year extension options and provides for an initial rental rate of 9%, with consumer price-indexed increases, limited to a 2% floor and 5% ceiling annually thereafter. In addition, we made Ernest a $100 million loan secured by a first mortgage interest in four subsidiaries of Ernest, which has terms similar to the leasing terms described above.

Acquisition Loan and Equity Contribution

Through an affiliate of one of our TRSs, we made investments of approximately $96.5 million in Ernest Health Holdings, LLC (“Ernest Holdings”), which is the owner of Ernest. These investments, which are structured as a $93.2 million loan and a $3.3 million equity contribution generally provide that we will receive a preferential return of 15% of the loan amount and approximately 79% of the remaining earnings of Ernest. Ernest is required to pay us a minimum of 6% and 7% of the loan amount in years one and two, respectively, and 10% thereafter, although there are provisions in the loan agreement that are expected to result in full payment of the 15% preference when funds are sufficient. Any of the 15% in excess of the minimum that is not paid may be accrued and paid upon the occurrence of a capital or liquidity event and is payable at maturity. The loan may be prepaid without penalty at any time.

Financing of Ernest Transaction

To finance the Ernest Transaction, we completed equity and senior unsecured notes offerings in February 2012. See Notes 4 and 5 for more information on these financing activities.

2011 Activity

On January 4, 2011, we acquired the real estate of the 19-bed, 4-year old Gilbert Hospital in a suburb of Phoenix, Arizona area for $17.1 million. Gilbert Hospital is operated by affiliates of Visionary Health, LLC. We acquired this asset subject to an existing lease that expires in May 2022.

On January 31, 2011, we acquired for $23.5 million the real estate of the 60-bed Atrium Medical Center at Corinth in the Dallas area, a long-term acute care hospital that was completed in 2009 and is subject to a lease that expires in June 2024. In addition, through one of our affiliates, we invested $1.3 million to acquire approximately 19% of a joint venture arrangement with an affiliate of Vibra Healthcare, LLC (“Vibra”) that will manage and has acquired a 51% interest in the operations of the facility. We also made a $5.2 million working capital loan to the joint venture. The former operators of the hospital, comprised primarily of local physicians, retained ownership of 49% of the operating entity.

On February 4, 2011, we purchased for $58 million the real estate of Bayonne Medical Center, a 6-story, 278-bed acute care hospital in the New Jersey area of metropolitan New York, and leased the facility to the operator under a 15-year lease, with six 5-year extension options. The operator is an affiliate of a private hospital operating company that acquired the hospital in 2008.

On February 9, 2011, we acquired the real estate of the 306-bed Alvarado Hospital in San Diego, California for $70 million from Prime who is the operator of the facility.

On February 14, 2011, we completed the acquisition of the Northland LTACH Hospital located in Kansas City, a 35-bed hospital that opened in April 2008 and has a lease that expires in 2028. This hospital is currently being operated by Kindred Healthcare Inc. The purchase price of this hospital was $19.5 million, which included the assumption of a mortgage loan.

On July 18, 2011, we acquired the real estate of the 40-bed Vibra Specialty Hospital of DeSoto in Desoto, Texas for $13.0 million. Vibra Specialty Hospital of DeSoto is a long-term acute care hospital. This facility is leased to a subsidiary of Vibra for a fixed term of 15 years with options to extend. In addition, we made a $2.5 million equity investment in the operator of this facility for a 25% equity ownership.

On September 30, 2011, we purchased the real estate of a 40-bed long-term acute care facility in New Braunfels, Texas for $10.0 million. This facility is leased to an affiliate of Post Acute Medical, LLC for a fixed term of 15 years with options to extend. In addition, we made a $1.4 million equity investment for a 25% equity ownership in the operator of this facility and funded a $2.0 million working capital loan.

As part of these acquisitions, we purchased and invested in the following assets during the first nine months: (dollar amounts in thousands)


	2012		2011
Assets Acquired
Land	$	—	$	17,218
Building		—		178,535
Intangible lease assets — subject to amortization (weighted average useful life of 13.5 years in 2011)		—		15,351
Net investments in direct financing leases		310,000		—
Mortgage loans		200,000		—
Other loans		93,200		7,233
Equity investments		3,300		5,168

Total assets acquired	$	606,500	$	223,505
Total liabilities assumed		—		(14,592	)

Net assets acquired	$	606,500	$	208,913

From the respective acquisition dates, the properties and mortgage loans acquired in 2012 contributed $14.1 million and $29.1 million of revenue and income (excluding related acquisition expenses) for the three and nine month periods ended September 30, 2012, respectively. In addition, we incurred $0.1 million and $3.8 million of acquisition related costs on the 2012 acquisitions for the three and nine months ended September 30, 2012.

From the respective acquisition dates, the seven hospitals acquired in 2011 contributed $5.5 million and $14.0 million of revenue and $3.7 million and $9.1 million of income (excluding related acquisition expenses) for the three and nine months ended September 30, 2011, respectively. In addition, we incurred $0.5 million and $3.2 million of acquisition related costs on consummated and non-consummated deals for the three and nine months ended September 30, 2011.

The results of operations for each of the properties acquired are included in our consolidated results from the effective date of each acquisition. The following table sets forth certain unaudited pro forma consolidated financial data for 2012 and 2011, as if each acquisition in 2012 and 2011 were consummated on the same terms at the beginning of 2011. Supplemental pro forma earnings were adjusted to exclude acquisition-related costs on consummated deals incurred in the three and nine months ended September 30, 2012 and 2011 (dollar amounts in thousands except per share/unit data).


	For the Three Months Ended September 30,				For the Nine Months Ended September 30,
	2012		2011		2012		2011
Total revenues	$	56,557	$	53,943	$	166,952	$	162,593
Net income		33,834		13,846		82,822		56,733
Net income per share/unit — diluted	$	0.25	$	0.10	$	0.61	$	0.42

Development Activities

On June 13, 2012, we entered into an agreement with Ernest to develop and lease a 40-bed rehabilitation hospital in Lafayette, Indiana. Total development cost is estimated to be $16.6 million and the facility is expected to be completed in the 2013 second quarter. We have funded $7.2 million through the third quarter of 2012.

On May 4, 2012, we amended the current lease on our Victoria, Texas facility with Post Acute Medical to extend the current lease term into 2028, and we agreed to develop and lease a 26-bed facility next to the current facility. Total development cost of the new facility is estimated to be $9.4 million and it is expected to be completed in the third quarter of 2013.

On March 1, 2012, we received a certificate of occupancy for our recently constructed Florence acute care facility near Phoenix, Arizona. With this, we started recognizing rent on this facility in March 2012. During the construction period, we accrued and deferred rent based on the cost paid during the construction period. In March 2012, we began recognizing a portion of the accrued construction period rent along with interest on the unpaid amount. This accrued construction period rent will be recognized in our income statement and paid over the 25 year lease term. Land and building costs associated with this property approximates $30 million.

In addition to the new development projects, our other three development projects, which will be leased to Emerus Holding, Inc., are expected to be completed between October 2012 and early 2013. Estimated total development cost for these three facilities is $30 million. We have funded $17.6 million through the third quarter of 2012. In regard to our River Oaks facility, re-development efforts continue and we currently expect this facility to be partially occupied starting in the first quarter of 2013.

Disposals

During the third quarter of 2012, we entered into a definitive agreement to sell the real estate of two LTACH facilities, Thornton and New Bedford, to Vibra for total cash proceeds of $42 million. The sale of Thornton was completed on September 28, 2012, resulting in a gain of $8.4 million. Due to this sale, we wrote-off $1.6 million in straight-line rent receivables. The sale of New Bedford was completed on October 22, 2012, resulting in a gain of approximately $7.0 million. Associated with this sale, we will write-off $4.1 million in straight-line rent receivables in the fourth quarter 2012. At September 30, 2012, our New Bedford facility is classified as held for sale, which required us to reclassify the operating results of this facility for the current and all prior periods to discontinued operations and reclassify the related real estate to Real Estate Held for Sale.

On August 21, 2012, we sold our Denham Springs facility for $5.2 million, resulting in a gain of $0.3 million. Due to this sale, the operating results of this facility for the current and all prior periods have been included in discontinued operations, and we have reclassified the related real estate to Real Estate Held for Sale.

On June 15, 2012, we sold the HealthSouth Rehabilitation Hospital of Fayetteville in Fayetteville, Arkansas for $16 million, resulting in a loss of $1.4 million. Due to this sale, the operating results of this facility for the current and all prior periods have been included in discontinued operations, and we have reclassified the related real estate to Real Estate Held for Sale. In connection with this sale, HealthSouth Corporation agreed to extend the lease on our Wichita, Kansas property, which is now set to end in March 2022.

Leasing Operations

On July 3, 2012, we entered into master lease agreements with certain subsidiaries of Prime, which replaced the then current leases with the same tenants covering the same properties. The master leases are for 10 years and contain two renewal options of five years each. The initial lease rate is generally consistent with the blended average rate of the prior lease agreements. However, the annual escalators, which in the prior leases were limited, have been increased to reflect 100% of CPI increases, along with a minimum floor. The master leases include repurchase options substantially similar to those in the prior leases, including provisions establishing minimum repurchase prices equal to our total investment.

As noted previously, we are accounting for the master lease of 12 Ernest facilities and our Roxborough and Reno facilities as a DFL. The components of our net investment in DFL consisted of the following (dollars in thousands):


	As of September 30, 2012
Minimum lease payments receivable	$	1,279,818
Estimated residual values		200,000
Less unearned income		(1,167,768	)

Net investment in direct financing leases	$	312,050

Monroe facility

As of September 30, 2012, we have advanced $29.9 million to the operator/lessee of Monroe Hospital in Bloomington, Indiana pursuant to a working capital loan agreement, but no additional advances were made during the 2012 third quarter. In addition, as of September 30, 2012, we have $19.0 million of rent, interest and other charges owed to us by the operator, of which $5.8 million of interest receivables are significantly more than 90 days past due. Because the operator has not made all payments required by the working capital loan agreement and the related real estate lease agreement, we consider the loan to be impaired. During 2010, we recorded a $12 million impairment charge on the working capital loan and recorded a valuation allowance for unbilled straight-line rent in the amount of $2.5 million. We have not recognized any interest income on the Monroe loan since it was considered impaired and have not recorded any unbilled rent since 2010.

At September 30, 2012, our net investment (exclusive of the related real estate) of approximately $37 million is our maximum exposure to Monroe and the amount is deemed collectible/recoverable. In making this determination, we considered our first priority secured interest in approximately (i) $5 million in hospital patient receivables, (ii) cash balances of approximately $0.1 million, (iii) our assessment of the realizable value of our other collateral and (iv) continued improvement in operational revenue statistics compared to previous years. However, no assurances can be made that we will not have additional charges for further impairment of our working capital loan in the future.

On September 4, 2012, Monroe Hospital entered into a four-year agreement with St. Vincent Health, Inc. whereby St. Vincent will manage the operations of the hospital. At the same time we agreed with St. Vincent to exclusively negotiate the terms of a possible sale or lease of the hospital real estate by the end of such four year term. St. Vincent is a member of Ascension Health, the largest Catholic health care system in the country. However, there is no assurance that we will reach a satisfactory agreement with St. Vincent and St. Vincent has certain rights to terminate the management agreement during the four year term.

Other Loan Activity

On March 1, 2012, pursuant to our convertible note agreement, we converted $1.6 million of our $5.0 million convertible note into a 9.9% equity interest in the operator of our Hoboken University Medical Center facility. At September 30, 2012, $3.4 million remains outstanding on the convertible note, and we retain the option, through November 2014, to convert this remainder into a 15.1% of equity interest in the operator.

Concentrations of Credit Risk

For the three and nine months ended September 30, 2012, revenue from affiliates of Ernest (including rent and interest from mortgage and acquisition loans) accounted for 20.8% and 18.1%, respectively, of total revenue. However, from an investment concentration perspective, Ernest represented 18.4% of our total assets at September 30, 2012.

For the three months ended September 30, 2012 and 2011, revenue from affiliates of Prime (including rent and interest from mortgage loans) accounted for 28.9% and 31.9%, respectively, of total revenue. For the nine months ended September 30, 2012 and 2011, revenue from affiliates of Prime (including rent and interest from mortgage loans) accounted for 26.3% and 31.7%, respectively, of total revenue. However, from an investment concentration perspective, Prime represented 28.7% and 25.3% of our total assets at September 30, 2012 and December 31, 2011, respectively.

On an individual property basis, we had no investment of any single property greater than 5% of our total assets as of September 30, 2012.

From a geographic perspective, all of our properties are located in the United States with 25.9% of our total assets at September 30, 2012 located in California.

Debt

9 Months Ended

Sep. 30, 2012

Debt

4. Debt

The following is a summary of debt, net of discounts (dollar amounts in thousands):


	As of September 30, 2012						As of December 31, 2011
	Balance			Interest Rate			Balance			Interest Rate
Revolving credit facilities (A)	$	125,000			Variable		$	89,600			Variable
2006 Senior Unsecured Notes		125,000			Various			125,000			Various
2011 Senior Unsecured Notes		450,000			6.875	%		450,000			6.875	%
2012 Senior Unsecured Notes		200,000			6.375	%		—
Exchangeable senior notes:
Principal amount		11,000			9.250	%		11,000			9.250	%
Unamortized discount		(75	)					(180	)

		10,925						10,820
Term loans		114,258			Various			14,429			6.200	%

	$	1,025,183					$	689,849

(A)	Our $42 million collateralized revolving credit facility expired in June 2012.

As of September 30, 2012, principal payments due for our debt (which exclude the effects of any discounts recorded) are as follows (in thousands):


2012	$	61
2013		11,249
2014		265
2015		125,283
2016		225,299
Thereafter		663,101

Total	$	1,025,258

To help fund the 2012 acquisitions disclosed in Note 3, on February 17, 2012, we completed a $200 million offering of senior unsecured notes (“2012 Senior Unsecured Notes”), resulting in net proceeds, after underwriting discount, of $196.5 million. These 2012 senior unsecured notes accrue interest at a fixed rate of 6.375% per year and mature on February 15, 2022. The 2012 Senior Unsecured Notes include covenants substantially consistent with our 2011 Senior Unsecured Notes.

In addition, on March 9, 2012, we closed on a $100 million senior unsecured term loan facility (“2012 Term Loan”) and exercised the $70 million accordion feature on our revolving credit facility, increasing its capacity from $330 million to $400 million ($125.0 million outstanding at September 30, 2012). The 2012 Term Loan facility has an interest rate option of (1) LIBOR plus an initial spread of 2.25% or (2) the higher of the “prime rate”, federal funds rate plus 0.5%, or Eurodollar rate plus 1.0%, plus an initial spread of 1.25%. The 2012 Term Loan facility is scheduled to mature on March 9, 2016, but we have the option to extend the facility one year to March 9, 2017.

During the second quarter 2010, we entered into an interest rate swap to fix $65 million of our 2006 Senior Unsecured Notes, which started July 31, 2011 (date on which the interest rate turned variable) through maturity date (or July 2016), at a rate of 5.507%. We also entered into an interest rate swap to fix $60 million of our 2006 Senior Unsecured Notes which started October 31, 2011 (date on which the related interest rate turned variable) through the maturity date (or October 2016) at a rate of 5.675%. At September 30, 2012 and December 31, 2011, the fair value of the interest rate swaps was $13.2 million and $12.2 million, respectively, which is reflected in accounts payable and accrued expenses on the condensed consolidated balance sheets.

We designated our interest rate swaps as cash flow hedges. Accordingly, the effective portion of changes in the fair value of our swaps is recorded as a component of accumulated other comprehensive income/loss on the balance sheet and reclassified into earnings in the same period, or periods, during which the hedged transactions effect earnings, while any ineffective portion is recorded through earnings immediately. We did not have any hedge ineffectiveness in the periods; therefore, there was no income statement effect recorded during the three and nine month periods ended September 30, 2012 or 2011. We do not expect any of the current losses included in accumulated other comprehensive loss to be reclassified into earnings in the next 12 months. At September 30, 2012 and December 31, 2011, we had $6.7 million and $6.3 million, respectively, posted as collateral, which is currently reflected in other assets on our consolidated balance sheets.

Our debt facilities impose certain restrictions on us, including restrictions on our ability to: incur debts; create or incur liens; provide guarantees in respect of obligations of any other entity; make redemptions and repurchases of our capital stock; prepay, redeem or repurchase debt; engage in mergers or consolidations; enter into affiliated transactions; dispose of real estate or other assets; and change our business. In addition, the credit agreements governing our revolving credit facility and 2012 Term Loan limit the amount of dividends we can pay as a percentage of normalized adjusted funds from operations, as defined in the agreements, on a rolling four quarter basis. Through the quarter ending June 30, the dividend restriction was 115% of normalized adjusted FFO. Thereafter, a similar dividend restriction exists but the percentage drops each quarter (110% for quarter ending September 30, 2012) until reaching 95% at September 30, 2013. The indentures governing our 2011 and 2012 Senior Unsecured Notes also limit the amount of dividends we can pay based on the sum of 95% of funds from operations, proceeds of equity issuances and certain other net cash proceeds. Finally, our 2011 and 2012 Senior Unsecured Notes require us to maintain total unencumbered assets (as defined in the related indenture) of not less than 150% of our unsecured indebtedness.

In addition to these restrictions, the revolving credit facility and 2012 Term Loan contain customary financial and operating covenants, including covenants relating to our total leverage ratio, fixed charge coverage ratio, mortgage secured leverage ratio, recourse mortgage secured leverage ratio, consolidated adjusted net worth, facility leverage ratio, and borrowing base interest coverage ratio. This facility also contains customary events of default, including among others, nonpayment of principal or interest, material inaccuracy of representations and failure to comply with our covenants. If an event of default occurs and is continuing under the facility, the entire outstanding balance may become immediately due and payable. At September 30, 2012, we were in compliance with all such financial and operating covenants.

Common Stock/Partner's Capital

9 Months Ended

Sep. 30, 2012

Common Stock/Partner's Capital

5. Common Stock/Partner’s Capital

Medical Properties Trust, Inc.

To help fund the 2012 acquisitions disclosed in Note 3, on February 7, 2012, we completed an offering of 23,575,000 shares of our common stock (including 3,075,000 shares sold pursuant to the exercise in full of the underwriters’ overallotment option) at a price of $9.75 per share, resulting in net proceeds (after underwriting discount) of $220.1 million.

MPT Operating Partnership, L.P.

At September 30, 2012, the Company has a 99.8% ownership interest in Operating Partnership with the remainder owned by three other partners, two of which are employees and one of which is a director. During the nine months ended September 30, 2012, the partnership issued 23,575,000 units in direct response to the common stock offering by Medical Properties Trust, Inc.

Stock Awards

9 Months Ended

Sep. 30, 2012

Stock Awards

6. Stock Awards

Our Second Amended and Restated Medical Properties Trust, Inc. 2004 Equity Incentive Plan (the “Equity Incentive Plan”) authorizes the issuance of common stock options, restricted stock, restricted stock units, deferred stock units, stock appreciation rights, performance units and awards of interests in our Operating Partnership. The Equity Incentive Plan is administered by the Compensation Committee of the Board of Directors. We have reserved 7,441,180 shares of common stock for awards under the Equity Incentive Plan for which 1,436,693 shares remain available for future stock awards as of September 30, 2012. We awarded the following during 2012 and 2011:

Time-based awards — We granted 275,464 and 292,803 shares in 2012 and 2011, respectively, of time-based restricted stock to management, independent directors, and certain employees (2011 only). These awards vest quarterly based on service, over three years, in equal amounts.

Performance-based awards — Our management team and certain employees (2011 only) were awarded 252,566 and 253,655 performance based awards in 2012 and 2011, respectively. These awards vest ratably over a three year period based on the achievement of certain total shareholder return measures, with a carry-back and carryforward provision through December 31, 2015 (for the 2011 awards) and December 31, 2016 (for the 2012 awards). Dividends on these awards are paid only upon achievement of the performance measures.

Multi-year Performance-based awards — We awarded 649,793 and 600,000 shares in 2012 and 2011, respectively, of multi-year performance-based awards to management and certain employees. These shares are subject to three-year cumulative performance hurdles based on total shareholder return. At the end of the third-year performance period, any earned shares will be subject to an additional two years of ratable time-based vesting on an annual basis. Dividends are paid on these shares only upon achievement of the performance measures.

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 40
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 14

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 123R
-Paragraph 64, 65, A240
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Statement of Position (SOP)
-Number 93-6
-Paragraph 53
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Fair Value of Financial Instruments

9 Months Ended

Sep. 30, 2012

Fair Value of Financial Instruments

7. Fair Value of Financial Instruments

We have various assets and liabilities that are considered financial instruments. We estimate that the carrying value of cash and cash equivalents, and accounts payable and accrued expenses approximate their fair values. Included in our accounts payable and accrued expenses are our interest rate swaps, which are recorded at fair value based on Level 2 observable market assumptions using standardized derivative pricing models. We estimate the fair value of our interest and rent receivables using Level 2 inputs such as discounting the estimated future cash flows using the current rates at which similar receivables would be made to others with similar credit ratings and for the same remaining maturities. The fair value of our mortgage loans and working capital loans is generally estimated by using Level 2 and Level 3 inputs such as discounting the estimated future cash flows using the current rates which similar loans would be made to borrowers with similar credit ratings and for the same remaining maturities. We determine the fair value of our exchangeable notes and 2011 and 2012 Senior Unsecured Notes, using Level 2 inputs such as quotes from securities dealers and market makers. We estimate the fair value of our 2006 Senior Unsecured Notes, revolving credit facilities, and term loans using Level 2 inputs based on the present value of future payments, discounted at a rate which we consider appropriate for such debt.

Fair value estimates are made at a specific point in time, are subjective in nature, and involve uncertainties and matters of significant judgment. Settlement of such fair value amounts may not be possible and may not be a prudent management decision. The following table summarizes fair value estimates for our financial instruments (in thousands):


	September 30, 2012						December 31, 2011
Asset (Liability)	Book Value			Fair Value			Book Value			Fair Value
Interest and rent receivables	$	42,094		$	34,166		$	29,862		$	22,866
Loans (1)		333,627			333,275			239,839			243,272
Debt, net		(1,025,183	)		(1,080,514	)		(689,849	)		(688,032	)

(1)	Excludes loans related to the Ernest Transaction since they are recorded at fair value and discussed below.

Items Measured at Fair Value on a Recurring Basis

As discussed in Note 2, our equity interest in Ernest and related loans are being measured at fair value on a recurring basis. At September 30, 2012, these amounts were as follows (in thousands):


Asset Type	Fair Value		Cost		Asset Type Classification
Mortgage loans	$	100,000	$	100,000	Mortgage loans
Acquisition loan		93,200		93,200	Other loans
Equity investments		3,300		3,300	Other assets

	$	196,500	$	196,500

Our mortgage loans with Ernest are recorded at fair value based on Level 3 inputs by discounting the estimated cash flows using the current rates which similar loans would be made to borrowers with similar credit ratings and the same remaining maturities. Our acquisition loan and equity investments are recorded at fair value based on Level 3 inputs, by using a discounted cash flow model, which requires significant estimates of our investee such as projected revenue and expenses and appropriate discount rates based on the risk profile of comparable companies. We classify these loans and equity investments as Level 3, as we use certain unobservable inputs to the valuation methodology that are significant to the fair value measurement, and the valuation requires management judgment due to the absence of quoted market prices. For these cash flow models, our observable inputs include capitalization rates and market interest rates, and our unobservable input includes our adjustment for minority discount, which was 500 basis points at September 30, 2012.

For the quarter and nine month period ended September 30, 2012, we had no gains/losses from fair value adjustments in our income statement. However, we recorded $5.7 million and $13.5 million of interest on these loans during the three and nine months ended September 30, 2012, respectively.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7578670&loc=d3e19207-110258

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14172-108612

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 21
-URI http://asc.fasb.org/extlink&oid=7491637&loc=d3e13537-108611

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=7491637&loc=d3e13504-108611

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=7491637&loc=d3e13433-108611

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 15B
-Subparagraph a, b
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 133
-Paragraph 44A, 44B
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 159
-Paragraph 17-22, 27, 28
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 15A
-Subparagraph a-d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 15C, 15D
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 157
-Paragraph 32, 33, 34
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 3, 10, 14, 15
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Discontinued Operations

9 Months Ended

Sep. 30, 2012

Discontinued Operations

8. Discontinued Operations

As disclosed in Note 3, we sold our Thornton facility in Colorado and our Denham Springs facility in Louisiana in the 2012 third quarter and our HealthSouth Rehabilitation Hospital of Fayetteville in Fayetteville, Arkansas during the 2012 second quarter. In addition, our New Bedford facility was sold in October 2012, and at September 30, 2012, we reclassified the New Bedford facility as held for sale.

On December 30, 2011, we sold Mountain View Regional Rehabilitation Hospital in Morgantown, West Virginia to HealthSouth Corporation for $21.1 million, resulting in a gain of $2.3 million. We also sold Sherman Oaks Hospital in Sherman Oaks, California to Prime, on December 30, 2011 for $20.0 million, resulting in a gain of $3.1 million. Due to this sale, we wrote-off $1.2 million in straight-line rent receivables.

The following table presents the results of discontinued operations, which include the revenue and expenses of the previously-owned facilities noted above, for the three and nine months ended September 30, 2012 and 2011 (dollar amounts in thousands except per share/unit amounts):


	For the Three Months Ended September 30,					For the Nine Months Ended September 30,
	2012			2011		2012		2011
Revenues	$	(342	)	$	3,159	$	3,455	$	7,820
Gain on sale		8,726			—		7,280		5
Income		8,028			2,372		9,169		4,944
Earnings per share/unit — diluted	$	0.06		$	0.02	$	0.07	$	0.05

- Definition

The entire disclosure for the facts and circumstances leading to the completed or expected disposal, manner and timing of disposal, the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss), amounts of revenues and pretax profit or loss reported in discontinued operations, the segment in which the disposal group was reported, and the classification (whether sold or classified as held for sale) and carrying value of the assets and liabilities comprising the disposal group. Includes all disposal groups, including those classified as components of the entity (discontinued operations).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1436-107760

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1510-107760

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1474-107760

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e1020-107759

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e957-107759

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e1012-107759

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=8077374&loc=d3e2443-110228

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6391110&loc=d3e2941-110230

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 144
-Paragraph 43-48
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Earnings Per Share/Common Unit

9 Months Ended

Sep. 30, 2012

Earnings Per Share/Common Unit

9. Earnings Per Share/Common Unit

Medical Properties Trust, Inc.

Our earnings per share were calculated based on the following (in thousands):


	For the Three Months Ended September 30,
	2012			2011
Numerator:
Income (loss) from continuing operations	$	23,480		$	(1,904	)
Non-controlling interests’ share in continuing operations		(44	)		(43	)
Participating securities’ share in earnings		(225	)		(264	)

Income (loss) from continuing operations, less participating securities’ share in earnings		23,211			(2,211	)
Income from discontinued operations attributable to MPT common stockholders		8,028			2,372

Net income, less participating securities’ share in earnings	$	31,239		$	161


	For the Three Months Ended September 30,
	2012		2011
Denominator
Basic weighted-average common shares		134,781		110,714
Dilutive share options		1		5

Dilutive weighted-average common shares		134,782		110,719


	For the Nine Months Ended September 30,
	2012			2011
Numerator:
Income from continuing operations	$	52,305		$	9,031
Non-controlling interests’ share in continuing operations		(130	)		(131	)
Participating securities’ share in earnings		(715	)		(860	)

Income from continuing operations, less participating securities’ share in earnings		51,460			8,040
Income from discontinued operations attributable to MPT common stockholders		9,169			4,944

Net income, less participating securities’ share in earnings	$	60,629		$	12,984


	For the Nine Months Ended September 30,
	2012		2011
Denominator

Basic weighted-average common shares		131,467		110,568
Dilutive share options		—		8

Dilutive weighted-average common shares		131,467		110,576

MPT Operating Partnership, L.P.

Our earnings per common unit were calculated based on the following (amounts in thousands):


	For the Three Months Ended September 30,
	2012			2011
Numerator:
Income (loss) from continuing operations	$	23,480		$	(1,886	)
Non-controlling interests’ share in continuing operations		(44	)		(43	)
Participating securities’ share in earnings		(225	)		(264	)

Income (loss) from continuing operations, less participating securities’ share in earnings		23,211			(2,193	)
Income from discontinued operations attributable to MPT Operating Partnership partners		8,028			2,372

Net income, less participating securities’ share in earnings	$	31,239		$	179


Denominator
Basic weighted-average units		134,781			110,714
Dilutive options		1			5

Dilutive weighted-average units		134,782			110,719


	For the Nine Months Ended September 30,
	2012			2011
Numerator:
Income from continuing operations	$	52,305		$	9,093
Non-controlling interests’ share in continuing operations		(130	)		(131	)
Participating securities’ share in earnings		(715	)		(860	)

Income from continuing operations, less participating securities’ share in earnings		51,460			8,102
Income from discontinued operations attributable to MPT Operating Partnership partners		9,169			4,944

Net income, less participating securities’ share in earnings	$	60,629		$	13,046


Denominator
Basic weighted-average units		131,467			110,568
Dilutive options		—			8

Dilutive weighted-average units		131,467			110,576

For the three and nine months ended September 30, 2012 and 2011, 0.1 million of options were excluded from the diluted earnings per share/unit calculation as they were not determined to be dilutive. Shares/units that may be issued in the future in accordance with our exchangeable senior notes were excluded from the diluted earnings per share/unit calculation as they were not determined to be dilutive.

Contingencies	9 Months Ended
Contingencies	Sep. 30, 2012
Contingencies	10. Contingencies We are a party to various legal proceedings incidental to our business. In the opinion of management, after consultation with legal counsel, the ultimate liability, if any, with respect to those proceedings is not presently expected to materially affect our financial position, results of operations or cash flows.

- Definition

The entire disclosure for commitments and contingencies.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 460
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6398077&loc=d3e12565-110249

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6952336&loc=d3e14435-108349

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.25)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Interpretation (FIN)
-Number 14
-Paragraph 3
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 5
-Paragraph 9, 10, 11, 12
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Subsequent Events	9 Months Ended
Subsequent Events	Sep. 30, 2012
Subsequent Events	11. Subsequent Events In October 2012, we agreed to fund the construction of an inpatient rehabilitation hospital in Spartanburg, SC that will be operated by Ernest. The estimated cost for the development is $18 million, and the construction is expected to be completed by the third quarter of 2013.

Condensed Consolidating Financial Information

9 Months Ended

Sep. 30, 2012

Condensed Consolidating Financial Information

12. Condensed Consolidating Financial Information

The following tables present the condensed consolidating financial information for (a) Medical Properties Trust, Inc. (“Parent” and a guarantor to our 2011 and 2012 Senior Unsecured Notes), (b) MPT Operating Partnership, L.P. and MPT Finance Corporation (“Subsidiary Issuer”), (c) on a combined basis, the guarantors of our 2011 and 2012 Senior Unsecured Notes (“Subsidiary Guarantors”), and (d) on a combined basis, the non-guarantor subsidiaries (“Non-Guarantor Subsidiaries”). Separate financial statements of the Subsidiary Guarantors are not presented because the guarantee by each 100% owned Subsidiary Guarantor is joint and several, and we believe separate financial statements and other disclosures regarding the Subsidiary Guarantors are not material to investors. Furthermore, there are no significant legal restrictions on the Parent’s ability to obtain funds from its subsidiaries by dividend or loan.

The guarantees by the Subsidiary Guarantors may be released and discharged upon: (1) any sale, exchange or transfer of all of the capital stock of a Subsidiary Guarantor; (2) the merger or consolidation of a Subsidiary Guarantor with a Subsidiary Issuer or any other Subsidiary Guarantor; (3) the proper designation of any Subsidiary Guarantor by the Subsidiary Issuers as “unrestricted” for covenant purposes under the indenture governing the 2011 and 2012 Senior Unsecured Notes; (4) the legal defeasance or covenant defeasance or satisfaction and discharge of the indenture; (5) a liquidation or dissolution of a Subsidiary Guarantor permitted under the indenture governing the 2011 and 2012 Senior Unsecured Notes; or (6) the release or discharge of the Subsidiary Guarantor from its guarantee obligations under our revolving credit facility.

Subsequent to December 31, 2011, certain of our subsidiaries were re-designated as guarantors of our 2011 and 2012 Senior Unsecured Notes (such subsidiaries were non-guarantors in 2011), while other subsidiaries have been re-designated as non-guarantors as the underlying properties were sold in 2012 (such subsidiaries were guarantors during 2011). With these re-designations, we have restated the 2011 condensed consolidating financial information below to reflect these changes.

Condensed Consolidated Balance Sheet

September 30, 2012

(in thousands)


	Parent		Subsidiary Issuers		Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Assets
Real estate assets
Land, buildings and improvements and intangible lease assets	$	—	$	42	$	1,185,920		$	65,947		$	—		$	1,251,909
Real estate held for sale		—		—		17,432			—			—			17,432
Mortgage loans		—		—		268,650			100,000			—			368,650
Net investment in direct financing leases		—		—		110,000			202,050			—			312,050

Gross investment in real estate assets		—		42		1,582,002			367,997			—			1,950,041
Accumulated depreciation and amortization		—		—		(114,188	)		(6,027	)		—			(120,215	)

Net investment in real estate assets				42		1,467,814			361,970			—			1,829,826
Cash & cash equivalents		—		34,371		1,565			227			—			36,163
Interest and rent receivable		—		540		27,881			13,673			—			42,094
Straight-line rent receivable		—		—		31,882			6,183			—			38,065
Other loans		—		176		—			158,001			—			158,177
Net intercompany receivable (payable)		26,750		1,410,629		(1,039,740	)		(397,639	)		—			—
Investment in subsidiaries		1,033,548		602,443		43,693			—			(1,679,684	)		—
Other assets		—		32,330		1,148			20,596			—			54,074

Total Assets	$	1,060,298	$	2,080,531	$	534,243		$	163,011		$	(1,679,684	)	$	2,158,399

Liabilities and Equity
Liabilities
Debt, net	$	—	$	1,010,925	$	—		$	14,258		$	—		$	1,025,183
Accounts payable and accrued expenses		27,140		35,958		731			468			—			64,297
Deferred revenue		—		100		18,796			1,478			—			20,374
Lease deposits and other obligations to tenants		—		—		14,372			1,015			—			15,387

Total liabilities		27,140		1,046,983		33,899			17,219			—			1,125,241
Total equity		1,033,158		1,033,548		500,344			145,792			(1,679,684	)		1,033,158

Total Liabilities and Equity	$	1,060,298	$	2,080,531	$	534,243		$	163,011		$	(1,679,684	)	$	2,158,399

Condensed Consolidated Statements of Income

For the Three Months Ended September 30, 2012

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Revenues
Rent billed	$	—		$	—		$	29,256	$	4,162		$	(2,335	)	$	31,083
Straight-line rent		—			—			2,387		375			—			2,762
Income from direct financing leases		—			—			5,238		5,394			(4,859	)		5,773
Interest and fee income		—			5,242			8,917		6,943			(7,065	)		14,037

Total revenues		—			5,242			45,798		16,874			(14,259	)		53,655
Expenses
Real estate depreciation and amortization		—			—			8,066		425			—			8,491
Property-related		—			88			121		7,203			(7,194	)		218
General and administrative		—			6,332			—		720			—			7,052
Acquisition expenses		—			410			—		—			—			410

Total operating expenses		—			6,830			8,187		8,348			(7,194	)		16,171

Operating income (expense)		—			(1,588	)		37,611		8,526			(7,065	)		37,484
Other income (expense)
Interest and other income (expense)		—			(21	)		—		(2	)		—			(23	)
Earnings from equity and other interests		—			—			330		735			—			1,065
Interest expense		—			(15,203	)		389		(7,297	)		7,065			(15,046	)

Net other income (expense)		—			(15,224	)		719		(6,564	)		7,065			(14,004	)

Income (loss) from continuing operations		—			(16,812	)		38,330		1,962			—			23,480
Income (loss) from discontinued operations		—			—			1,069		6,959			—			8,028
Equity in earnings of consolidated subsidiaries net of income taxes		31,508			48,320			1,129		—			(80,957	)		—

Net income (loss)		31,508			31,508			40,528		8,921			(80,957	)		31,508
Net income (loss) attributable to non-controlling interests		(44	)		(44	)		—		—			44			(44	)

Net income (loss) attributable to MPT common stockholders	$	31,464		$	31,464		$	40,528	$	8,921		$	(80,913	)	$	31,464

Condensed Consolidated Statements of Income

For the Nine Months Ended September 30, 2012

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Revenues
Rent billed	$	—		$	—		$	87,579		$	12,447		$	(6,926	)	$	93,100
Straight-line rent		—			—			4,354			1,119			—			5,473
Income from direct financing leases		—			—			11,730			12,600			(11,351	)		12,979
Interest and fee income		—			13,219			20,621			17,357			(17,711	)		33,486

Total revenues		—			13,219			124,284			43,523			(35,988	)		145,038
Expenses
Real estate depreciation and amortization		—			—			24,117			1,275			—			25,392
Property-related		—			349			597			18,375			(18,277	)		1,044
General and administrative		—			20,067			—			1,274			—			21,341
Acquisition expenses		—			4,115			—			—			—			4,115

Total operating expenses		—			24,531			24,714			20,924			(18,277	)		51,892

Operating income (expense)		—			(11,312	)		99,570			22,599			(17,711	)		93,146
Other income (expense)
Interest and other income (expense)		—			(49	)		(2	)		(4	)		—			(55	)
Earnings from equity and other interests		—			—			783			1,161			—			1,944
Interest expense		—			(42,905	)		867			(18,403	)		17,711			(42,730	)

Net other income (expense)		—			(42,954	)		1,648			(17,246	)		17,711			(40,841	)

Income (loss) from continuing operations		—			(54,266	)		101,218			5,353			—			52,305
Income (loss) from discontinued operations		—			—			2,363			6,806			—			9,169
Equity in earnings of consolidated subsidiaries net of income taxes		61,474			115,740			3,367			—			(180,581	)		—

Net income (loss)		61,474			61,474			106,948			12,159			(180,581	)		61,474
Net income (loss) attributable to non-controlling interests		(130	)		(130	)		—			—			130			(130	)

Net income (loss) attributable to MPT common stockholders	$	61,344		$	61,344		$	106,948		$	12,159		$	(180,451	)	$	61,344

Condensed Consolidated Statements of Comprehensive Income (Loss)

For the Three Months Ended September 30, 2012

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries		Eliminations			Total Consolidated
Net income	$	31,508		$	31,508		$	40,528	$	8,921	$	(80,957	)	$	31,508
Other comprehensive income:
Unrealized loss on interest rate swap		(443	)		(443	)		—		—		443			(443	)

Total comprehensive income		31,065			31,065			40,528		8,921		(80,514	)		31,065
Comprehensive income attributable to non-controlling interests		(44	)		(44	)		—		—		44			(44	)

Comprehensive income attributable to MPT common stockholders	$	31,021		$	31,021		$	40,528	$	8,921	$	(80,470	)	$	31,021

Condensed Consolidated Statements of Comprehensive Income (Loss)

For the Nine Months Ended September 30, 2012

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries		Eliminations			Total Consolidated
Net income	$	61,474		$	61,474		$	106,948	$	12,159	$	(180,581	)	$	61,474
Other comprehensive income:
Unrealized loss on interest rate swap		(989	)		(989	)		—		—		989			(989	)

Total comprehensive income		60,485			60,485			106,948		12,159		(179,592	)		60,485
Comprehensive income attributable to non-controlling interests		(130	)		(130	)		—		—		130			(130	)

Comprehensive income attributable to MPT common stockholders	$	60,355		$	60,355		$	106,948	$	12,159	$	(179,462	)	$	60,355

Condensed Consolidated Statements of Cash Flows

For the Nine Months Ended September 30, 2012

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Operating Activities
Net cash provided by (used in) operating activities	$	16		$	(38,780	)	$	114,073		$	(600	)	$	—		$	74,709
Investing Activities
Cash paid for acquisitions and other related investments		—			—			(410,000	)		(196,500	)		—			(606,500	)
Principal received on loans receivable		—			—			5,491			4,016			—			9,507
Net proceeds from sales of real estate		—			—			800			33,300			—			34,100
Investments in and advances to subsidiaries		(143,554	)		(540,016	)		377,472			162,560			143,538			—
Investments in loans receivable		—			—			—			(1,293	)		—			(1,293	)
Construction in progress and other		—			(59	)		(34,349	)		(1,512	)		—			(35,920	)

Net cash provided by (used in) investing activities		(143,554	)		(540,075	)		(60,586	)		571			143,538			(600,106	)
Financing Activities
Revolving credit facilities, net		—			75,000			(39,600	)		—			—			35,400
Additions to term debt		—			300,000			—			—			—			300,000
Payments of term debt		—			—			—			(171	)		—			(171	)
Distributions paid		(76,569	)		(76,770	)		—			—			76,569			(76,770	)
Sale of common stock, net		220,107			220,107			—			—			(220,107	)		220,107
Lease deposits and other obligations to tenants		—			—			(13,731	)		340			—			(13,391	)
Debt issuance costs paid and other financing activities		—			(6,341	)		—			—			—			(6,341	)

Net cash provided by (used in) financing activities		143,538			511,996			(53,331	)		169			(143,538	)		458,834

Increase in cash and cash equivalents for period		—			(66,859	)		156			140			—			(66,563	)
Cash and cash equivalents at beginning of period		—			101,230			1,409			87			—			102,726

Cash and cash equivalents at end of period	$	—		$	34,371		$	1,565		$	227		$	—		$	36,163

Condensed Consolidated Balance Sheet

December 31, 2011

(in thousands)


	Parent		Subsidiary Issuers		Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Assets
Real estate assets
Land, buildings and improvements and intangible lease assets	$	—	$	37	$	1,151,574		$	65,948		$	—		$	1,217,559
Real estate held for sale		—		—		22,008			26,917			—			48,925
Mortgage loans		—		—		165,000			—			—			165,000

Gross investment in real estate assets		—		37		1,338,582			92,865			—			1,431,484
Accumulated depreciation and amortization		—		—		(90,072	)		(4,750	)		—			(94,822	)

Net investment in real estate assets		—		37		1,248,510			88,115			—			1,336,662
Cash & cash equivalents		—		101,230		1,409			87			—			102,726
Interest and rent receivable		—		399		22,528			6,935			—			29,862
Straight-line rent receivable		—		—		27,388			6,605			—			33,993
Other loans		—		178		5,491			69,170			—			74,839
Net intercompany receivable (payable)		21,955		872,380		(862,281	)		(32,054	)		—			—
Investment in subsidiaries		829,205		489,858		43,008			—			(1,362,071	)		—
Other assets		—		27,285		2,151			14,356			—			43,792

Total Assets	$	851,160	$	1,491,367	$	488,204		$	153,214		$	(1,362,071	)	$	1,621,874

Liabilities and Equity
Liabilities
Debt, net	$	—	$	635,820	$	39,600		$	14,429		$	—		$	689,849
Accounts payable and accrued expenses		22,345		25,783		2,578			419			—			51,125
Deferred revenue		—		559		21,372			1,376			—			23,307
Lease deposits and other obligations to tenants		—		—		28,103			675			—			28,778

Total liabilities		22,345		662,162		91,653			16,899			—			793,059
Total equity		828,815		829,205		396,551			136,315			(1,362,071	)		828,815

Total Liabilities and Equity	$	851,160	$	1,491,367	$	488,204		$	153,214		$	(1,362,071	)	$	1,621,874

Condensed Consolidated Statements of Income

For the Three Months Ended September 30, 2011

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Revenues
Rent billed	$	—		$	—		$	25,903	$	2,188		$	(331	)	$	27,760
Straight-line rent		—			—			1,219		424			—			1,643
Interest and fee income		—			1,351			4,146		920			(1,188	)		5,229

Total revenues		—			1,351			31,268		3,532			(1,519	)		34,632
Expenses
Real estate depreciation and amortization		—			—			7,212		488			—			7,700
Property-related		—			87			171		333			(331	)		260
General and administrative		18			6,348			—		(629	)		—			5,737
Acquisition expenses		—			513			469		(452	)		—			530

Total operating expenses		18			6,948			7,852		(260	)		(331	)		14,227

Operating income (loss)		(18	)		(5,597	)		23,416		3,792			(1,188	)		20,405
Other income (expense)
Interest and other income (expense)		—			44			—		(2	)		—			42
Earnings from equity and other interests		—			—			84		(75	)		—			9
Debt refinancing costs		—			(10,425	)		—		—			—			(10,425	)
Interest expense		—			(11,735	)		63		(1,451	)		1,188			(11,935	)

Net other income (expense)		—			(22,116	)		147		(1,528	)		1,188			(22,309	)

Income (loss) from continuing operations		(18	)		(27,713	)		23,563		2,264			—			(1,904	)
Income (loss) from discontinued operations		—			—			787		1,585			—			2,372
Equity in earnings of consolidated subsidiaries net of income taxes		486			28,199			1,112		—			(29,797	)		—

Net income (loss)		468			486			25,462		3,849			(29,797	)		468
Net income (loss) attributable to non-controlling interests		(43	)		(43	)		—		—			43			(43	)

Net income attributable to MPT common stockholders	$	425		$	443		$	25,462	$	3,849		$	(29,754	)	$	425

Condensed Consolidated Statements of Income

For the Nine Months Ended September 30, 2011

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Revenues
Rent billed	$	—		$	—		$	76,284		$	5,796		$	(994	)	$	81,086
Straight-line rent		—			—			3,974			1,344			—			5,318
Interest and fee income		—			4,118			13,087			2,597			(4,088	)		15,714

Total revenues		—			4,118			93,345			9,737			(5,082	)		102,118
Expenses
Real estate depreciation and amortization		—			—			21,216			1,292			—			22,508
Property-related		—			87			213			1,040			(994	)		346
General and administrative		62			18,356			—			2,011			—			20,429
Acquisition expenses		—			2,717			469			—			—			3,186

Total operating expenses		62			21,160			21,898			4,343			(994	)		46,469

Operating income (loss)		(62	)		(17,042	)		71,447			5,394			(4,088	)		55,649
Other income (expense)
Interest income and other		—			42			2			(56	)		—			(12	)
Earnings from equity and other interests		—			—			84			(14	)		—			70
Debt refinancing costs		—			(14,109	)		(105	)		—			—			(14,214	)
Interest expense		—			(31,750	)		(31	)		(4,769	)		4,088			(32,462	)

Net other income (expense)		—			(45,817	)		(50	)		(4,839	)		4,088			(46,618	)

Income (loss) from continuing operations		(62	)		(62,859	)		71,397			555			—			9,031
Income (loss) from discontinued operations		—			—			263			4,681			—			4,944
Equity in earnings of consolidated subsidiaries net of income taxes		14,037			76,896			3,457			—			(94,390	)		—

Net income (loss)		13,975			14,037			75,117			5,236			(94,390	)		13,975
Net income (loss) attributable to non-controlling interests		(131	)		(131	)		—			—			131			(131	)

Net income attributable to MPT common stockholders	$	13,844		$	13,906		$	75,117		$	5,236		$	(94,259	)	$	13,844

Condensed Consolidated Statements of Comprehensive Income (Loss)

For the Three Months Ended September 30, 2011

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries		Eliminations			Total Consolidated
Net income (loss)	$	468		$	486		$	25,462	$	3,849	$	(29,797	)	$	468
Other comprehensive income (loss):
Unrealized loss on interest rate swap		(5,272	)		(5,272	)		—		—		5,272			(5,272	)

Total comprehensive income (loss)		(4,804	)		(4,786	)		25,462		3,849		(24,525	)		(4,804	)
Comprehensive income attributable to non-controlling interests		(43	)		(43	)		—		—		43			(43	)


Comprehensive income (loss) attributable to MPT common stockholders	$	(4,847	)	$	(4,829	)	$	25,462	$	3,849	$	(24,482	)	$	(4,847	)

Condensed Consolidated Statements of Comprehensive Income (Loss)

For the Nine Months Ended September 30, 2011

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries		Eliminations			Total Consolidated
Net income	$	13,975		$	14,037		$	75,117	$	5,236	$	(94,390	)	$	13,975
Other comprehensive income:
Unrealized loss on interest rate swap		(8,341	)		(8,341	)		—		—		8,341			(8,341	)

Total comprehensive income		5,634			5,696			75,117		5,236		(86,049	)		5,634
Comprehensive income attributable to non-controlling interests		(131	)		(131	)		—		—		131			(131	)

Comprehensive income attributable to MPT common stockholders	$	5,503		$	5,565		$	75,117	$	5,236	$	(85,918	)	$	5,503

Condensed Consolidated Statements of Cash Flows

For the Nine Months Ended September 30, 2011

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Operating Activities
Net cash provided by (used in) operating activities	$	(124	)	$	(26,727	)	$	86,364		$	7,615		$	—		$	67,128
Investing Activities
Cash paid for acquisitions and other related investments		—			—			(191,625	)		(17,288	)		—			(208,913	)
Principal received on loans receivable		—			—			—			2,898			—			2,898
Investments in and advances to subsidiaries		67,126			(89,763	)		81,565			8,074			(67,002	)		—
Investments in loans receivable		—			(205	)		(3,314	)		(879	)		—			(4,398	)
Construction in progress and other		—			—			(12,297	)		—			—			(12,297	)

Net cash provided by (used in) investing activities		67,126			(89,968	)		(125,671	)		(7,195	)		(67,002	)		(222,710	)
Financing Activities
Revolving credit facilities, net		—			—			39,600			—			—			39,600
Additions to term debt		—			450,000			—			—			—			450,000
Payments of term debt		—			(229,271	)		(8,433	)		(106	)		—			(237,810	)
Distributions paid		(67,002	)		(67,194	)		—			—			67,002			(67,194	)
Lease deposits and other obligations to tenants		—			—			8,140			(527	)		—			7,613
Debt issuance costs paid and other financing activities		—			(20,530	)		—			(137	)		—			(20,667	)

Net cash provided by (used in) financing activities		(67,002	)		133,005			39,307			(770	)		67,002			171,542

Increase (decrease) in cash and cash equivalents for period		—			16,310			—			(350	)		—			15,960
Cash and cash equivalents at beginning of period		—			96,822			—			1,586			—			98,408

Cash and cash equivalents at end of period	$	—		$	113,132		$	—		$	1,236		$	—		$	114,368

- Definition

The entire disclosure for condensed financial information, including the financial position, cash flows, and the results of operations of the registrant (parent company) as of the same dates or for the same periods for which audited consolidated financial statements are being presented. Alternatively, the details of this disclosure can be reported by the specific parent company taxonomy elements, indicating the appropriate date and period contexts in an instance document.

+ References + Details

Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2012

Unaudited Interim Condensed Consolidated Financial Statements

Variable Interest Entities

Variable Interest Entities


VIE Type	Maximum Loss Exposure(1)		Asset Type Classification	Carrying Amount(2)
Loans, net	$	274,073	Mortgage and other loans	$	230,105
Equity investments	$	13,764	Other assets	$	3,179

(1)

(2)	Carrying amount reflects the net book value of our loan or equity interest only in the VIE.

See Note 3 for additional description of the nature, purpose and activities of our more significant VIEs and interests therein.

- Definition

Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2197480

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 860
-SubTopic 40
-Section 45
-URI http://asc.fasb.org/section&trid=2197723

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2196966

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 325
-SubTopic 20
-URI http://asc.fasb.org/subtopic&trid=2197087

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.3A-02)
-URI http://asc.fasb.org/extlink&oid=6959686&loc=d3e355033-122828

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=16385135&loc=d3e33801-111570

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=18733093&loc=d3e5614-111684

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Interpretation (FIN)
-Number 46R
-Paragraph 4
-Subparagraph c
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Principles Board Opinion (APB)
-Number 18
-Paragraph 5, 6, 16-19
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Emerging Issues Task Force (EITF)
-Number 96-16
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Interpretation (FIN)
-Number 46R
-Paragraph 4
-Subparagraph d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Principles Board Opinion (APB)
-Number 18
-Paragraph 20
-Subparagraph a(2)
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 2-6
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Emerging Issues Task Force (EITF)
-Number 97-2
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph k
-Article 1

Reference 17: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 140
-Paragraph 46
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 18: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02, 03
-Article 3A

Reference 19: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Interpretation (FIN)
-Number 46R
-Paragraph 14, 15
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

- Definition

Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 5A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=7880789&loc=SL6759159-111685

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2197480

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=7880789&loc=d3e5728-111685

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 2AA
-Subparagraph a
-URI http://asc.fasb.org/extlink&oid=7880789&loc=SL6759068-111685

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Interpretation (FIN)
-Number 46R
-Paragraph 14, 15
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 167
-Paragraph 24
-Subparagraph e
-Appendix D

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 167
-Paragraph 22E
-Subparagraph a
-Appendix D

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 167
-Paragraph 22B
-Subparagraph a
-Appendix D

+ Details

Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2012

Carrying Value and Classification of Related Assets and Maximum Exposure to Loss as Result of Involvement with Variable Interest Entities

the primary beneficiary. The carrying value and classification of the related assets and maximum exposure to loss as a result of our involvement with these VIEs are presented below at September 30, 2012 (in thousands):


VIE Type	Maximum Loss Exposure(1)		Asset Type Classification	Carrying Amount(2)
Loans, net	$	274,073	Mortgage and other loans	$	230,105
Equity investments	$	13,764	Other assets	$	3,179

(1)

(2)	Carrying amount reflects the net book value of our loan or equity interest only in the VIE.

- Definition

Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=7880789&loc=d3e5747-111685

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=7880789&loc=SL6228884-111685

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=7880789&loc=d3e5728-111685

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Variable Interest Entity
-URI http://asc.fasb.org/extlink&oid=6528138

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=7880789&loc=d3e5710-111685

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 5A
-URI http://asc.fasb.org/extlink&oid=7880789&loc=SL6759159-111685

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 140
-Paragraph 35
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Interpretation (FIN)
-Number 46R
-Paragraph 2, 14, 15, 16, 23, 24, 25, 26
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 167
-Paragraph 24
-Appendix D

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Staff Position (FSP)
-Number FAS140-4/FIN46(R)-8
-Paragraph C4
-Subparagraph d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 167
-Paragraph 22B
-Appendix D

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 167
-Paragraph 23A
-Appendix D

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 167
-Paragraph 22E
-Appendix D

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Interpretation (FIN)
-Number 46R
-Paragraph 4
-Subparagraph g
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Real Estate and Lending Activities (Tables)

9 Months Ended

Sep. 30, 2012

List of Assets Purchased and Invested as Part of Acquisitions

As part of these acquisitions, we purchased and invested in the following assets during the first nine months: (dollar amounts in thousands)


	2012		2011
Assets Acquired
Land	$	—	$	17,218
Building		—		178,535
Intangible lease assets — subject to amortization (weighted average useful life of 13.5 years in 2011)		—		15,351
Net investments in direct financing leases		310,000		—
Mortgage loans		200,000		—
Other loans		93,200		7,233
Equity investments		3,300		5,168

Total assets acquired	$	606,500	$	223,505
Total liabilities assumed		—		(14,592	)

Net assets acquired	$	606,500	$	208,913

Unaudited Pro Forma Consolidated Financial Data

The following table sets forth certain unaudited pro forma consolidated financial data for 2012 and 2011, as if each acquisition in 2012 and 2011 were consummated on the same terms at the beginning of 2011. Supplemental pro forma earnings were adjusted to exclude acquisition-related costs on consummated deals incurred in the three and nine months ended September 30, 2012 and 2011 (dollar amounts in thousands except per share/unit data).


	For the Three Months Ended September 30,				For the Nine Months Ended September 30,
	2012		2011		2012		2011
Total revenues	$	56,557	$	53,943	$	166,952	$	162,593
Net income		33,834		13,846		82,822		56,733
Net income per share/unit — diluted	$	0.25	$	0.10	$	0.61	$	0.42

Components of Net Investments in Direct Financing Lease

we are accounting for the master lease of 12 Ernest facilities and our Roxborough and Reno facilities as a DFL. The components of our net investment in DFL consisted of the following (dollars in thousands):


	As of September 30, 2012
Minimum lease payments receivable	$	1,279,818
Estimated residual values		200,000
Less unearned income		(1,167,768	)

Net investment in direct financing leases	$	312,050

- Definition

Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.

+ References + Details

- Definition

Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1486-128463

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1392-128463

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 51
-Subparagraph a
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph F4
-Subparagraph e
-Appendix F

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 52
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 68
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Debt (Tables)

9 Months Ended

Sep. 30, 2012

Summary of Debt, Net of Discounts

The following is a summary of debt, net of discounts (dollar amounts in thousands):


	As of September 30, 2012						As of December 31, 2011
	Balance			Interest Rate			Balance			Interest Rate
Revolving credit facilities (A)	$	125,000			Variable		$	89,600			Variable
2006 Senior Unsecured Notes		125,000			Various			125,000			Various
2011 Senior Unsecured Notes		450,000			6.875	%		450,000			6.875	%
2012 Senior Unsecured Notes		200,000			6.375	%		—
Exchangeable senior notes:
Principal amount		11,000			9.250	%		11,000			9.250	%
Unamortized discount		(75	)					(180	)

		10,925						10,820
Term loans		114,258			Various			14,429			6.200	%

	$	1,025,183					$	689,849

(A)	Our $42 million collateralized revolving credit facility expired in June 2012.

Principal Payments Due for Debt

As of September 30, 2012, principal payments due for our debt (which exclude the effects of any discounts recorded) are as follows (in thousands):


2012	$	61
2013		11,249
2014		265
2015		125,283
2016		225,299
Thereafter		663,101

Total	$	1,025,258

Fair Value of Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2012

Summary of Fair Value Estimates for Financial Instruments

prudent management decision. The following table summarizes fair value estimates for our financial instruments (in thousands):


	September 30, 2012						December 31, 2011
Asset (Liability)	Book Value			Fair Value			Book Value			Fair Value
Interest and rent receivables	$	42,094		$	34,166		$	29,862		$	22,866
Loans (1)		333,627			333,275			239,839			243,272
Debt, net		(1,025,183	)		(1,080,514	)		(689,849	)		(688,032	)

(1)	Excludes loans related to the Ernest Transaction since they are recorded at fair value and discussed below.

Equity Interest in Ernest and Related Loans Measured at Fair Value on Recurring Basis

As discussed in Note 2, our equity interest in Ernest and related loans are being measured at fair value on a recurring basis. At September 30, 2012, these amounts were as follows (in thousands):


Asset Type	Fair Value		Cost		Asset Type Classification
Mortgage loans	$	100,000	$	100,000	Mortgage loans
Acquisition loan		93,200		93,200	Other loans
Equity investments		3,300		3,300	Other assets

	$	196,500	$	196,500

- Definition

Tabular disclosure of the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments, assets, and liabilities. Such certain disclosures about the financial instruments, assets, and liabilities include: (1) the fair value of the required items together with their carrying amounts (as appropriate) and (2) the methodology and assumptions used in developing such estimates of fair value.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=7491637&loc=d3e13476-108611

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=7578670&loc=d3e19207-110258

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=7491637&loc=d3e13467-108611

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6447952&loc=d3e13220-108610

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14172-108612

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 10
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=7491637&loc=d3e13433-108611

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 159
-Paragraph 19
-Subparagraph a, b, c(1), d(1)
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 14
-Subparagraph a
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 15
-Subparagraph b-d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 159
-Paragraph 18
-Subparagraph c(2), d, e, f
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 157
-Paragraph 32
-Subparagraph a, c(1), c(2), c(3), d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 10
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Discontinued Operations (Tables)

9 Months Ended

Sep. 30, 2012

Discontinued Operations


	For the Three Months Ended September 30,					For the Nine Months Ended September 30,
	2012			2011		2012		2011
Revenues	$	(342	)	$	3,159	$	3,455	$	7,820
Gain on sale		8,726			—		7,280		5
Income		8,028			2,372		9,169		4,944
Earnings per share/unit — diluted	$	0.06		$	0.02	$	0.07	$	0.05

- Definition

Tabular disclosure of disposal groups, which may include the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss), amounts of revenues and pretax profit or loss reported in discontinued operations, the classification and carrying value of the assets and liabilities comprising the disposal group, and the segment in which the disposal group was reported. Also may include the amount of adjustments to amounts previously reported in discontinued operations such as resolution of contingencies arising from the disposal transaction or the operations of the component prior to disposal.

+ References + Details

Earnings Per Share/Common Unit (Tables)

9 Months Ended

Sep. 30, 2012

MPT Operating Partnership, L.P.

Earnings Per Share/Common Unit

Medical Properties Trust, Inc.

Our earnings per share were calculated based on the following (in thousands):


	For the Three Months Ended September 30,
	2012			2011
Numerator:
Income (loss) from continuing operations	$	23,480		$	(1,904	)
Non-controlling interests’ share in continuing operations		(44	)		(43	)
Participating securities’ share in earnings		(225	)		(264	)

Income (loss) from continuing operations, less participating securities’ share in earnings		23,211			(2,211	)
Income from discontinued operations attributable to MPT common stockholders		8,028			2,372

Net income, less participating securities’ share in earnings	$	31,239		$	161


	For the Three Months Ended September 30,
	2012		2011
Denominator
Basic weighted-average common shares		134,781		110,714
Dilutive share options		1		5

Dilutive weighted-average common shares		134,782		110,719


	For the Nine Months Ended September 30,
	2012			2011
Numerator:
Income from continuing operations	$	52,305		$	9,031
Non-controlling interests’ share in continuing operations		(130	)		(131	)
Participating securities’ share in earnings		(715	)		(860	)

Income from continuing operations, less participating securities’ share in earnings		51,460			8,040
Income from discontinued operations attributable to MPT common stockholders		9,169			4,944

Net income, less participating securities’ share in earnings	$	60,629		$	12,984


	For the Nine Months Ended September 30,
	2012		2011
Denominator

Basic weighted-average common shares		131,467		110,568
Dilutive share options		—		8

Dilutive weighted-average common shares		131,467		110,576

Medical Properties Trust, Inc.

Earnings Per Share/Common Unit

Our earnings per common unit were calculated based on the following (amounts in thousands):


	For the Three Months Ended September 30,
	2012			2011
Numerator:
Income (loss) from continuing operations	$	23,480		$	(1,886	)
Non-controlling interests’ share in continuing operations		(44	)		(43	)
Participating securities’ share in earnings		(225	)		(264	)

Income (loss) from continuing operations, less participating securities’ share in earnings		23,211			(2,193	)
Income from discontinued operations attributable to MPT Operating Partnership partners		8,028			2,372

Net income, less participating securities’ share in earnings	$	31,239		$	179


Denominator
Basic weighted-average units		134,781			110,714
Dilutive options		1			5

Dilutive weighted-average units		134,782			110,719


	For the Nine Months Ended September 30,
	2012			2011
Numerator:
Income from continuing operations	$	52,305		$	9,093
Non-controlling interests’ share in continuing operations		(130	)		(131	)
Participating securities’ share in earnings		(715	)		(860	)

Income from continuing operations, less participating securities’ share in earnings		51,460			8,102
Income from discontinued operations attributable to MPT Operating Partnership partners		9,169			4,944

Net income, less participating securities’ share in earnings	$	60,629		$	13,046


Denominator
Basic weighted-average units		131,467			110,568
Dilutive options		—			8

Dilutive weighted-average units		131,467			110,576

Condensed Consolidating Financial Information (Tables)

9 Months Ended

Sep. 30, 2012

Condensed Consolidated Balance Sheet

Condensed Consolidated Balance Sheet

September 30, 2012

(in thousands)


	Parent		Subsidiary Issuers		Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Assets
Real estate assets
Land, buildings and improvements and intangible lease assets	$	—	$	42	$	1,185,920		$	65,947		$	—		$	1,251,909
Real estate held for sale		—		—		17,432			—			—			17,432
Mortgage loans		—		—		268,650			100,000			—			368,650
Net investment in direct financing leases		—		—		110,000			202,050			—			312,050

Gross investment in real estate assets		—		42		1,582,002			367,997			—			1,950,041
Accumulated depreciation and amortization		—		—		(114,188	)		(6,027	)		—			(120,215	)

Net investment in real estate assets				42		1,467,814			361,970			—			1,829,826
Cash & cash equivalents		—		34,371		1,565			227			—			36,163
Interest and rent receivable		—		540		27,881			13,673			—			42,094
Straight-line rent receivable		—		—		31,882			6,183			—			38,065
Other loans		—		176		—			158,001			—			158,177
Net intercompany receivable (payable)		26,750		1,410,629		(1,039,740	)		(397,639	)		—			—
Investment in subsidiaries		1,033,548		602,443		43,693			—			(1,679,684	)		—
Other assets		—		32,330		1,148			20,596			—			54,074

Total Assets	$	1,060,298	$	2,080,531	$	534,243		$	163,011		$	(1,679,684	)	$	2,158,399

Liabilities and Equity
Liabilities
Debt, net	$	—	$	1,010,925	$	—		$	14,258		$	—		$	1,025,183
Accounts payable and accrued expenses		27,140		35,958		731			468			—			64,297
Deferred revenue		—		100		18,796			1,478			—			20,374
Lease deposits and other obligations to tenants		—		—		14,372			1,015			—			15,387

Total liabilities		27,140		1,046,983		33,899			17,219			—			1,125,241
Total equity		1,033,158		1,033,548		500,344			145,792			(1,679,684	)		1,033,158

Total Liabilities and Equity	$	1,060,298	$	2,080,531	$	534,243		$	163,011		$	(1,679,684	)	$	2,158,399

Condensed Consolidated Balance Sheet

December 31, 2011

(in thousands)


	Parent		Subsidiary Issuers		Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Assets
Real estate assets
Land, buildings and improvements and intangible lease assets	$	—	$	37	$	1,151,574		$	65,948		$	—		$	1,217,559
Real estate held for sale		—		—		22,008			26,917			—			48,925
Mortgage loans		—		—		165,000			—			—			165,000

Gross investment in real estate assets		—		37		1,338,582			92,865			—			1,431,484
Accumulated depreciation and amortization		—		—		(90,072	)		(4,750	)		—			(94,822	)

Net investment in real estate assets		—		37		1,248,510			88,115			—			1,336,662
Cash & cash equivalents		—		101,230		1,409			87			—			102,726
Interest and rent receivable		—		399		22,528			6,935			—			29,862
Straight-line rent receivable		—		—		27,388			6,605			—			33,993
Other loans		—		178		5,491			69,170			—			74,839
Net intercompany receivable (payable)		21,955		872,380		(862,281	)		(32,054	)		—			—
Investment in subsidiaries		829,205		489,858		43,008			—			(1,362,071	)		—
Other assets		—		27,285		2,151			14,356			—			43,792

Total Assets	$	851,160	$	1,491,367	$	488,204		$	153,214		$	(1,362,071	)	$	1,621,874

Liabilities and Equity
Liabilities
Debt, net	$	—	$	635,820	$	39,600		$	14,429		$	—		$	689,849
Accounts payable and accrued expenses		22,345		25,783		2,578			419			—			51,125
Deferred revenue		—		559		21,372			1,376			—			23,307
Lease deposits and other obligations to tenants		—		—		28,103			675			—			28,778

Total liabilities		22,345		662,162		91,653			16,899			—			793,059
Total equity		828,815		829,205		396,551			136,315			(1,362,071	)		828,815

Total Liabilities and Equity	$	851,160	$	1,491,367	$	488,204		$	153,214		$	(1,362,071	)	$	1,621,874

Condensed Consolidated Statements of Income

Condensed Consolidated Statements of Income

For the Three Months Ended September 30, 2012

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Revenues
Rent billed	$	—		$	—		$	29,256	$	4,162		$	(2,335	)	$	31,083
Straight-line rent		—			—			2,387		375			—			2,762
Income from direct financing leases		—			—			5,238		5,394			(4,859	)		5,773
Interest and fee income		—			5,242			8,917		6,943			(7,065	)		14,037

Total revenues		—			5,242			45,798		16,874			(14,259	)		53,655
Expenses
Real estate depreciation and amortization		—			—			8,066		425			—			8,491
Property-related		—			88			121		7,203			(7,194	)		218
General and administrative		—			6,332			—		720			—			7,052
Acquisition expenses		—			410			—		—			—			410

Total operating expenses		—			6,830			8,187		8,348			(7,194	)		16,171

Operating income (expense)		—			(1,588	)		37,611		8,526			(7,065	)		37,484
Other income (expense)
Interest and other income (expense)		—			(21	)		—		(2	)		—			(23	)
Earnings from equity and other interests		—			—			330		735			—			1,065
Interest expense		—			(15,203	)		389		(7,297	)		7,065			(15,046	)

Net other income (expense)		—			(15,224	)		719		(6,564	)		7,065			(14,004	)

Income (loss) from continuing operations		—			(16,812	)		38,330		1,962			—			23,480
Income (loss) from discontinued operations		—			—			1,069		6,959			—			8,028
Equity in earnings of consolidated subsidiaries net of income taxes		31,508			48,320			1,129		—			(80,957	)		—

Net income (loss)		31,508			31,508			40,528		8,921			(80,957	)		31,508
Net income (loss) attributable to non-controlling interests		(44	)		(44	)		—		—			44			(44	)

Net income (loss) attributable to MPT common stockholders	$	31,464		$	31,464		$	40,528	$	8,921		$	(80,913	)	$	31,464

Condensed Consolidated Statements of Income

For the Nine Months Ended September 30, 2012

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Revenues
Rent billed	$	—		$	—		$	87,579		$	12,447		$	(6,926	)	$	93,100
Straight-line rent		—			—			4,354			1,119			—			5,473
Income from direct financing leases		—			—			11,730			12,600			(11,351	)		12,979
Interest and fee income		—			13,219			20,621			17,357			(17,711	)		33,486

Total revenues		—			13,219			124,284			43,523			(35,988	)		145,038
Expenses
Real estate depreciation and amortization		—			—			24,117			1,275			—			25,392
Property-related		—			349			597			18,375			(18,277	)		1,044
General and administrative		—			20,067			—			1,274			—			21,341
Acquisition expenses		—			4,115			—			—			—			4,115

Total operating expenses		—			24,531			24,714			20,924			(18,277	)		51,892

Operating income (expense)		—			(11,312	)		99,570			22,599			(17,711	)		93,146
Other income (expense)
Interest and other income (expense)		—			(49	)		(2	)		(4	)		—			(55	)
Earnings from equity and other interests		—			—			783			1,161			—			1,944
Interest expense		—			(42,905	)		867			(18,403	)		17,711			(42,730	)

Net other income (expense)		—			(42,954	)		1,648			(17,246	)		17,711			(40,841	)

Income (loss) from continuing operations		—			(54,266	)		101,218			5,353			—			52,305
Income (loss) from discontinued operations		—			—			2,363			6,806			—			9,169
Equity in earnings of consolidated subsidiaries net of income taxes		61,474			115,740			3,367			—			(180,581	)		—

Net income (loss)		61,474			61,474			106,948			12,159			(180,581	)		61,474
Net income (loss) attributable to non-controlling interests		(130	)		(130	)		—			—			130			(130	)

Net income (loss) attributable to MPT common stockholders	$	61,344		$	61,344		$	106,948		$	12,159		$	(180,451	)	$	61,344

Condensed Consolidated Statements of Income

For the Three Months Ended September 30, 2011

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Revenues
Rent billed	$	—		$	—		$	25,903	$	2,188		$	(331	)	$	27,760
Straight-line rent		—			—			1,219		424			—			1,643
Interest and fee income		—			1,351			4,146		920			(1,188	)		5,229

Total revenues		—			1,351			31,268		3,532			(1,519	)		34,632
Expenses
Real estate depreciation and amortization		—			—			7,212		488			—			7,700
Property-related		—			87			171		333			(331	)		260
General and administrative		18			6,348			—		(629	)		—			5,737
Acquisition expenses		—			513			469		(452	)		—			530

Total operating expenses		18			6,948			7,852		(260	)		(331	)		14,227

Operating income (loss)		(18	)		(5,597	)		23,416		3,792			(1,188	)		20,405
Other income (expense)
Interest and other income (expense)		—			44			—		(2	)		—			42
Earnings from equity and other interests		—			—			84		(75	)		—			9
Debt refinancing costs		—			(10,425	)		—		—			—			(10,425	)
Interest expense		—			(11,735	)		63		(1,451	)		1,188			(11,935	)

Net other income (expense)		—			(22,116	)		147		(1,528	)		1,188			(22,309	)

Income (loss) from continuing operations		(18	)		(27,713	)		23,563		2,264			—			(1,904	)
Income (loss) from discontinued operations		—			—			787		1,585			—			2,372
Equity in earnings of consolidated subsidiaries net of income taxes		486			28,199			1,112		—			(29,797	)		—

Net income (loss)		468			486			25,462		3,849			(29,797	)		468
Net income (loss) attributable to non-controlling interests		(43	)		(43	)		—		—			43			(43	)

Net income attributable to MPT common stockholders	$	425		$	443		$	25,462	$	3,849		$	(29,754	)	$	425

Condensed Consolidated Statements of Income

For the Nine Months Ended September 30, 2011

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Revenues
Rent billed	$	—		$	—		$	76,284		$	5,796		$	(994	)	$	81,086
Straight-line rent		—			—			3,974			1,344			—			5,318
Interest and fee income		—			4,118			13,087			2,597			(4,088	)		15,714

Total revenues		—			4,118			93,345			9,737			(5,082	)		102,118
Expenses
Real estate depreciation and amortization		—			—			21,216			1,292			—			22,508
Property-related		—			87			213			1,040			(994	)		346
General and administrative		62			18,356			—			2,011			—			20,429
Acquisition expenses		—			2,717			469			—			—			3,186

Total operating expenses		62			21,160			21,898			4,343			(994	)		46,469

Operating income (loss)		(62	)		(17,042	)		71,447			5,394			(4,088	)		55,649
Other income (expense)
Interest income and other		—			42			2			(56	)		—			(12	)
Earnings from equity and other interests		—			—			84			(14	)		—			70
Debt refinancing costs		—			(14,109	)		(105	)		—			—			(14,214	)
Interest expense		—			(31,750	)		(31	)		(4,769	)		4,088			(32,462	)

Net other income (expense)		—			(45,817	)		(50	)		(4,839	)		4,088			(46,618	)

Income (loss) from continuing operations		(62	)		(62,859	)		71,397			555			—			9,031
Income (loss) from discontinued operations		—			—			263			4,681			—			4,944
Equity in earnings of consolidated subsidiaries net of income taxes		14,037			76,896			3,457			—			(94,390	)		—

Net income (loss)		13,975			14,037			75,117			5,236			(94,390	)		13,975
Net income (loss) attributable to non-controlling interests		(131	)		(131	)		—			—			131			(131	)

Net income attributable to MPT common stockholders	$	13,844		$	13,906		$	75,117		$	5,236		$	(94,259	)	$	13,844

Condensed Consolidated Statements of Comprehensive Income (Loss)

Condensed Consolidated Statements of Comprehensive Income (Loss)

For the Three Months Ended September 30, 2012

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries		Eliminations			Total Consolidated
Net income	$	31,508		$	31,508		$	40,528	$	8,921	$	(80,957	)	$	31,508
Other comprehensive income:
Unrealized loss on interest rate swap		(443	)		(443	)		—		—		443			(443	)

Total comprehensive income		31,065			31,065			40,528		8,921		(80,514	)		31,065
Comprehensive income attributable to non-controlling interests		(44	)		(44	)		—		—		44			(44	)

Comprehensive income attributable to MPT common stockholders	$	31,021		$	31,021		$	40,528	$	8,921	$	(80,470	)	$	31,021

Condensed Consolidated Statements of Comprehensive Income (Loss)

For the Nine Months Ended September 30, 2012

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries		Eliminations			Total Consolidated
Net income	$	61,474		$	61,474		$	106,948	$	12,159	$	(180,581	)	$	61,474
Other comprehensive income:
Unrealized loss on interest rate swap		(989	)		(989	)		—		—		989			(989	)

Total comprehensive income		60,485			60,485			106,948		12,159		(179,592	)		60,485
Comprehensive income attributable to non-controlling interests		(130	)		(130	)		—		—		130			(130	)

Comprehensive income attributable to MPT common stockholders	$	60,355		$	60,355		$	106,948	$	12,159	$	(179,462	)	$	60,355

Condensed Consolidated Statements of Comprehensive Income (Loss)

For the Three Months Ended September 30, 2011

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries		Eliminations			Total Consolidated
Net income (loss)	$	468		$	486		$	25,462	$	3,849	$	(29,797	)	$	468
Other comprehensive income (loss):
Unrealized loss on interest rate swap		(5,272	)		(5,272	)		—		—		5,272			(5,272	)

Total comprehensive income (loss)		(4,804	)		(4,786	)		25,462		3,849		(24,525	)		(4,804	)
Comprehensive income attributable to non-controlling interests		(43	)		(43	)		—		—		43			(43	)


Comprehensive income (loss) attributable to MPT common stockholders	$	(4,847	)	$	(4,829	)	$	25,462	$	3,849	$	(24,482	)	$	(4,847	)

Condensed Consolidated Statements of Comprehensive Income (Loss)

For the Nine Months Ended September 30, 2011

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries		Eliminations			Total Consolidated
Net income	$	13,975		$	14,037		$	75,117	$	5,236	$	(94,390	)	$	13,975
Other comprehensive income:
Unrealized loss on interest rate swap		(8,341	)		(8,341	)		—		—		8,341			(8,341	)

Total comprehensive income		5,634			5,696			75,117		5,236		(86,049	)		5,634
Comprehensive income attributable to non-controlling interests		(131	)		(131	)		—		—		131			(131	)

Comprehensive income attributable to MPT common stockholders	$	5,503		$	5,565		$	75,117	$	5,236	$	(85,918	)	$	5,503

Condensed Consolidated Statements of Cash Flows

Condensed Consolidated Statements of Cash Flows

For the Nine Months Ended September 30, 2012

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Operating Activities
Net cash provided by (used in) operating activities	$	16		$	(38,780	)	$	114,073		$	(600	)	$	—		$	74,709
Investing Activities
Cash paid for acquisitions and other related investments		—			—			(410,000	)		(196,500	)		—			(606,500	)
Principal received on loans receivable		—			—			5,491			4,016			—			9,507
Net proceeds from sales of real estate		—			—			800			33,300			—			34,100
Investments in and advances to subsidiaries		(143,554	)		(540,016	)		377,472			162,560			143,538			—
Investments in loans receivable		—			—			—			(1,293	)		—			(1,293	)
Construction in progress and other		—			(59	)		(34,349	)		(1,512	)		—			(35,920	)

Net cash provided by (used in) investing activities		(143,554	)		(540,075	)		(60,586	)		571			143,538			(600,106	)
Financing Activities
Revolving credit facilities, net		—			75,000			(39,600	)		—			—			35,400
Additions to term debt		—			300,000			—			—			—			300,000
Payments of term debt		—			—			—			(171	)		—			(171	)
Distributions paid		(76,569	)		(76,770	)		—			—			76,569			(76,770	)
Sale of common stock, net		220,107			220,107			—			—			(220,107	)		220,107
Lease deposits and other obligations to tenants		—			—			(13,731	)		340			—			(13,391	)
Debt issuance costs paid and other financing activities		—			(6,341	)		—			—			—			(6,341	)

Net cash provided by (used in) financing activities		143,538			511,996			(53,331	)		169			(143,538	)		458,834

Increase in cash and cash equivalents for period		—			(66,859	)		156			140			—			(66,563	)
Cash and cash equivalents at beginning of period		—			101,230			1,409			87			—			102,726

Cash and cash equivalents at end of period	$	—		$	34,371		$	1,565		$	227		$	—		$	36,163

Condensed Consolidated Statements of Cash Flows

For the Nine Months Ended September 30, 2011

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Operating Activities
Net cash provided by (used in) operating activities	$	(124	)	$	(26,727	)	$	86,364		$	7,615		$	—		$	67,128
Investing Activities
Cash paid for acquisitions and other related investments		—			—			(191,625	)		(17,288	)		—			(208,913	)
Principal received on loans receivable		—			—			—			2,898			—			2,898
Investments in and advances to subsidiaries		67,126			(89,763	)		81,565			8,074			(67,002	)		—
Investments in loans receivable		—			(205	)		(3,314	)		(879	)		—			(4,398	)
Construction in progress and other		—			—			(12,297	)		—			—			(12,297	)

Net cash provided by (used in) investing activities		67,126			(89,968	)		(125,671	)		(7,195	)		(67,002	)		(222,710	)
Financing Activities
Revolving credit facilities, net		—			—			39,600			—			—			39,600
Additions to term debt		—			450,000			—			—			—			450,000
Payments of term debt		—			(229,271	)		(8,433	)		(106	)		—			(237,810	)
Distributions paid		(67,002	)		(67,194	)		—			—			67,002			(67,194	)
Lease deposits and other obligations to tenants		—			—			8,140			(527	)		—			7,613
Debt issuance costs paid and other financing activities		—			(20,530	)		—			(137	)		—			(20,667	)

Net cash provided by (used in) financing activities		(67,002	)		133,005			39,307			(770	)		67,002			171,542

Increase (decrease) in cash and cash equivalents for period		—			16,310			—			(350	)		—			15,960
Cash and cash equivalents at beginning of period		—			96,822			—			1,586			—			98,408

Cash and cash equivalents at end of period	$	—		$	113,132		$	—		$	1,236		$	—		$	114,368

Carrying Value and Classification of Related Assets and Maximum Exposure to Loss as Result of Involvement with Variable Interest Entities (Detail)
$ in Thousands

Sep. 30, 2012

USD ($)

Loans, net

Variable Interest Entity [Line Items]

Maximum Loss Exposure

$ 274,073

^[1]

Equity Investments

Variable Interest Entity [Line Items]

Maximum Loss Exposure

13,764

^[1]

Mortgage and Other Loans

Variable Interest Entity [Line Items]

Carrying Amount

230,105

^[2]

Other Assets

Variable Interest Entity [Line Items]

Carrying Amount

$ 3,179

^[2]

[1]

[2]

Carrying amount reflects the net book value of our loan or equity interest only in the VIE.

Real Estate and Lending Activities - Additional Information (Detail) $ in Thousands	1 Months Ended														3 Months Ended				9 Months Ended		12 Months Ended
	Oct. 22, 2012 USD ($)	Sep. 04, 2012	Aug. 21, 2012 USD ($)	Jul. 03, 2012 USD ($)	Jun. 15, 2012 USD ($)	Jun. 13, 2012 USD ($)	May 04, 2012 USD ($)	Mar. 01, 2012 USD ($)	Sep. 30, 2011 USD ($) yr	Jul. 18, 2011 USD ($) yr	Feb. 14, 2011 USD ($)	Feb. 04, 2011 USD ($) yr	Jan. 31, 2011 USD ($)	Jan. 04, 2011 USD ($) yr	Dec. 31, 2012 USD ($)	Sep. 30, 2012 USD ($) Project	Sep. 30, 2011 USD ($) Entity	Mar. 31, 2010 USD ($)	Sep. 30, 2012 USD ($) Project yr Facility Property d	Sep. 30, 2011 USD ($) Entity	Dec. 31, 2011	Sep. 19, 2012 USD ($)	Feb. 29, 2012 USD ($)	Feb. 09, 2011 USD ($)
Significant Acquisitions and Disposals [Line Items]
Aggregate purchase price																			$ 200,000
Term of lease, year \| yr																			20
Number of lease extension options in current lease contract																3			3
Term of lease extension, years																			5 years
Percentage of rental rate																			9.00%
Loan secured by mortgage interest																$ 100,000			$ 100,000
Coupon payable in cash in, thereafter																			10.00%
Income contributed by acquired entity																33,834	$ 13,846		$ 82,822	$ 56,733
Sale of real estate																42,000
Amount of convertible note converted into equity interest								$ 1,600
Convertible note								$ 5,000
Percentage of equity shares from convertible debt								9.90%											15.10%
Remaining convertible debt after conversion of part of debt																$ 3,400			$ 3,400
Maximum percentage of entity's total assets invested on single property																5.00%			5.00%
United States
Significant Acquisitions and Disposals [Line Items]
Percentage of total assets accounted																			25.90%
Maximum
Significant Acquisitions and Disposals [Line Items]
Percentage of rental rate																			5.00%
Minimum
Significant Acquisitions and Disposals [Line Items]
Percentage of rental rate																			2.00%
Coupon payable in cash, year one																			6.00%
Coupon payable in cash, year two																			7.00%
HealthSouth Rehabilitation Hospital of Fayetteville
Significant Acquisitions and Disposals [Line Items]
Sale of real estate					$ 16,000
Gain (loss) on sale of real estate					$ (1,400)
Denham Springs Facility
Significant Acquisitions and Disposals [Line Items]
Sale of real estate			$ 5,200
Gain (loss) on sale of real estate			$ 300
Thornton
Significant Acquisitions and Disposals [Line Items]
Gain (loss) on sale of real estate																			$ 8,400
Straight-line rent write-off																			1,600
New Bedford \| Gain (Loss) on Disposition of Property
Significant Acquisitions and Disposals [Line Items]
Gain (loss) on sale of real estate	$ 7,000
New Bedford \| Asset Write Off
Significant Acquisitions and Disposals [Line Items]
Straight-line rent write-off															$ 4,100
Other Three Development Projects
Significant Acquisitions and Disposals [Line Items]
Estimated total development cost																			$ 30,000
Expected facility completion date																			between October 2012 and early 2013
Estimated total development cost, funded																$ 17,600
Number of development projects \| Project																3			3
Number of facilities \| Facility																			3
River Oaks facility
Significant Acquisitions and Disposals [Line Items]
Expected facility completion date																			First quarter of 2013
Ernest
Significant Acquisitions and Disposals [Line Items]
Purchase price of real estate																							$ 200,000
Combined purchase price and investment amount																							396,500
First mortgage loan																							100,000
Acquisition loan made																$ 93,200			$ 93,200				93,200
Capital contribution																							$ 3,300
Total investment																$ 96,500			$ 96,500
Preferential rate of return on loan amount																			15.00%
Preferential return on remaining earnings																			79.00%
Percentage of entity revenue from affiliates																20.80%			18.10%
Percentage of total assets accounted																			18.40%
Ernest \| Key Management Personnel
Significant Acquisitions and Disposals [Line Items]
Capital contribution																$ 3,300			$ 3,300
Rehabilitation Hospital
Significant Acquisitions and Disposals [Line Items]
Number of facilities acquired																			5
Acute Care Facility
Significant Acquisitions and Disposals [Line Items]
Number of beds acquired									40								40			40
Purchase price of real estate									$ 10,000								$ 10,000			$ 10,000
Number of facilities acquired																			7
Number of states																7			7
Term of lease, year \| yr									15
Date acquired																			Sep. 30, 2011
Payments to acquire equity method investments									$ 1,400
Ownership interest in equity									25.00%								25.00%			25.00%
Working capital loan to the joint venture									$ 2,000
Bayonne Medical Center
Significant Acquisitions and Disposals [Line Items]
Number of stories in building \| Property																			6
Vibra Specialty Hospital
Significant Acquisitions and Disposals [Line Items]
Number of beds acquired										40
Purchase price of real estate										$ 13,000
Term of lease, year \| yr										15
Date acquired																			Jul. 18, 2011
Payments to acquire equity method investments										$ 2,500
Ownership interest in equity										25.00%
Prime Health Care Services
Significant Acquisitions and Disposals [Line Items]
Number of beds at Centinela Hospital Medical Center used to secure loan				369
Master lease term				10 years
Master lease agreements, number of renewal options				2
Master lease, optional lease term				5 years
Lease escalation percentage				100.00%
Percentage of entity revenue from affiliates																28.90%	31.90%		26.30%	31.70%
Percentage of total assets accounted																			28.70%		25.30%
Prime Health Care Services \| Loans, net
Significant Acquisitions and Disposals [Line Items]
New mortgage loan funded				$ 100,000
Florence Facility
Significant Acquisitions and Disposals [Line Items]
Term of lease, year \| yr																			25
Cost of land and building																$ 30,000			$ 30,000
Monroe Hospital
Significant Acquisitions and Disposals [Line Items]
Revenue contributed by acquired entity																			19,000
Advanced amount of working capital loan agreement																29,900			29,900
Interest receivable																5,800			$ 5,800
Period past due, in days \| d																			90
Impairment of working capital loan recognized																		$ 12,000
Valuation allowance for rent																			$ 2,500
Net investment to maximum exposure																37,000			37,000
Impairment of working capital loan estimation-patient receivables considered for first priority secured interest																			5,000
Impairment of working capital loan estimation-cash balance considered for first priority secured interest																			$ 100
Management agreement period		4 years
Series of Individually Immaterial Business Acquisitions
Significant Acquisitions and Disposals [Line Items]
Ownership interest in equity													51.00%
Working capital loan to the joint venture													$ 5,200
Retained ownership in operating entity													49.00%
Revenue contributed by acquired entity																	$ 5,500			$ 14,000
Income contributed by acquired entity																	3,700			9,100
Acquisition related costs																	$ 500			$ 3,200
Number of business acquisitions in period \| Entity																	7			7
Series of Individually Immaterial Business Acquisitions \| Gilbert Hospital
Significant Acquisitions and Disposals [Line Items]
Number of beds acquired														19
Purchase price of real estate														$ 17,100
Age of real estate acquired \| yr														4
Date acquired																			Jan. 04, 2011
Lease expiration date														2022-05
Series of Individually Immaterial Business Acquisitions \| Atrium Medical Center
Significant Acquisitions and Disposals [Line Items]
Number of beds acquired													60
Purchase price of real estate													$ 23,500
Date acquired																			Jan. 31, 2011
Lease expiration date													2024-06
Date of construction													2009
Series of Individually Immaterial Business Acquisitions \| Vibra Health Care
Significant Acquisitions and Disposals [Line Items]
Payments to acquire equity method investments													$ 1,300
Ownership interest in equity													19.00%
Series of Individually Immaterial Business Acquisitions \| Bayonne Medical Center
Significant Acquisitions and Disposals [Line Items]
Number of beds acquired												278
Purchase price of real estate												$ 58,000
Term of lease, year \| yr												15
Number of lease extension options in current lease contract												6
Term of lease extension, years												5 years
Date acquired																			Feb. 04, 2011
Series of Individually Immaterial Business Acquisitions \| Alvarado Hospital
Significant Acquisitions and Disposals [Line Items]
Number of beds acquired																								306
Purchase price of real estate																								$ 70,000
Date acquired																			Feb. 09, 2011
Series of Individually Immaterial Business Acquisitions \| Northland Ltach Hospital
Significant Acquisitions and Disposals [Line Items]
Number of beds acquired											35
Purchase price of real estate											$ 19,500
Date acquired																			Feb. 14, 2011
Lease expiration year											2028
Construction completion date											2008-04
Series of Individually Immaterial Business Acquisitions \| St. Mary's Regional Medical Center
Significant Acquisitions and Disposals [Line Items]
Number of beds acquired																						380
Purchase price of real estate																						$ 80,000
Series of Individually Immaterial Business Acquisitions \| Roxborough Memorial Hospital
Significant Acquisitions and Disposals [Line Items]
Number of beds acquired																						140
Purchase price of real estate																						$ 30,000
Victoria, TX \| Acute Care Facility
Significant Acquisitions and Disposals [Line Items]
Number of beds acquired							26
Lease expiration year							2028
Estimated total development cost							$ 9,400
Expected facility completion date							third quarter of 2013
Twenty Twelve Acquisitions
Significant Acquisitions and Disposals [Line Items]
Revenue contributed by acquired entity																14,100			$ 29,100
Income contributed by acquired entity																14,100			29,100
Acquisition related costs																100			$ 3,800
Ernest \| Rehabilitation Hospital
Significant Acquisitions and Disposals [Line Items]
Number of beds acquired						40
Estimated total development cost						$ 16,600
Expected facility completion date						2013 second quarter
Estimated total development cost, funded																$ 7,200
Business acquisition agreement																			Jun. 13, 2012

List of Assets Purchased and Invested as Part of Acquisitions (Detail) - USD ($) $ in Thousands	Sep. 30, 2012	Sep. 30, 2011
Significant Acquisitions and Disposals [Line Items]
Total assets acquired	$ 606,500	$ 223,505
Total liabilities assumed		(14,592)
Net assets acquired	606,500	208,913
Land
Significant Acquisitions and Disposals [Line Items]
Total assets acquired		17,218
Building
Significant Acquisitions and Disposals [Line Items]
Total assets acquired		178,535
Intangible Lease Assets
Significant Acquisitions and Disposals [Line Items]
Total assets acquired		15,351
Net Investment in Direct Financing Leases
Significant Acquisitions and Disposals [Line Items]
Total assets acquired	310,000
Mortgage Loans
Significant Acquisitions and Disposals [Line Items]
Total assets acquired	200,000
Other loans
Significant Acquisitions and Disposals [Line Items]
Total assets acquired	93,200	7,233
Equity Investments
Significant Acquisitions and Disposals [Line Items]
Total assets acquired	$ 3,300	$ 5,168

List of Assets Purchased and Invested as Part of Acquisitions (Parenthetical) (Detail)	9 Months Ended
	Sep. 30, 2011
Intangible Lease Assets
Significant Acquisitions and Disposals [Line Items]
Weighted average useful life of acquired intangible lease assets (in years)	13 years 6 months

Unaudited Pro Forma Consolidated Financial Data (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Business Acquisition [Line Items]
Total revenues	$ 56,557	$ 53,943	$ 166,952	$ 162,593
Net income	$ 33,834	$ 13,846	$ 82,822	$ 56,733
Net income per share/unit - diluted	$ 0.25	$ 0.10	$ 0.61	$ 0.42

Components of Net Investments in Direct Financing Lease (Detail) $ in Thousands	Sep. 30, 2012 USD ($)
Rental Income [Line Items]
Minimum lease payments receivable	$ 1,279,818
Estimated residual values	200,000
Less unearned income	(1,167,768)
Net investment in direct financing leases	$ 312,050

Summary of Debt, Net of Discounts (Detail) - USD ($)
$ in Thousands

9 Months Ended

12 Months Ended

Sep. 30, 2012

Dec. 31, 2011

Feb. 17, 2012

Debt Instrument [Line Items]

Unamortized discount

$ (75)

$ (180)

Debt instrument, net

10,925

10,820

Debt, net

1,025,183

689,849

Revolving Credit Facilities

Debt Instrument [Line Items]

Principal amount

^[1]

$ 125,000

$ 89,600

Interest rate

^[1]

Variable

2006 Senior Unsecured Notes

Debt Instrument [Line Items]

Principal amount

$ 125,000

Interest rate

Various

2011 Senior Unsecured Notes

Debt Instrument [Line Items]

Principal amount

$ 450,000

Unsecured senior notes, interest rate

6.875%

2012 Senior Unsecured Notes

Debt Instrument [Line Items]

Principal amount

$ 200,000

Unsecured senior notes, interest rate

6.375%

Exchangeable Senior Notes

Debt Instrument [Line Items]

Principal amount

$ 11,000

Unsecured senior notes, interest rate

9.25%

Term Loans

Debt Instrument [Line Items]

Debt instrument, net

$ 114,258

$ 14,429

Unsecured senior notes, interest rate

6.20%

Interest rate

Various

[1]	Our $42 million collateralized revolving credit facility expired in June 2012.

Summary of Debt, Net of Discounts (Parenthetical) (Detail) - Revolving Credit Facilities - USD ($)
$ in Thousands

12 Months Ended

Dec. 31, 2011

Sep. 30, 2012

Debt Instrument [Line Items]

Principal amount

^[1]

$ 89,600

$ 125,000

Collateralized Debt Obligations

Debt Instrument [Line Items]

Principal amount

$ 42,000

Expiration date

2012-06

[1]	Our $42 million collateralized revolving credit facility expired in June 2012.

Principal Payments Due for Debt (Detail) $ in Thousands	Sep. 30, 2012 USD ($)
Debt Instrument [Line Items]
2012	$ 61
2013	11,249
2014	265
2015	125,283
2016	225,299
Thereafter	663,101
Total	$ 1,025,258

Debt - Additional Information (Detail) - USD ($) $ in Thousands	1 Months Ended			3 Months Ended			9 Months Ended		12 Months Ended
	Mar. 09, 2012	Feb. 17, 2012	Oct. 31, 2011	Sep. 30, 2012	Sep. 30, 2011	Jun. 30, 2010	Sep. 30, 2012	Sep. 30, 2011	Dec. 31, 2011
Debt Instrument [Line Items]
LIBOR plus spread interest rate	2.25%
Initial spread interest rate	1.25%
Other assets, collateral				$ 6,700			$ 6,700		$ 6,300
Hedge ineffectiveness and income statement effect in period				0	$ 0		$ 0	$ 0
Percentage of dividends which could be paid from adjusted operating funds							115.00%
Restricted percentage for future dividend payment							110.00%
Restricted percentage for dividend payment for next year							95.00%
Percentage of dividends which could be paid from operation funds							95.00%
Maximum percentage of total unencumbered assets							150.00%		150.00%
Interest Rate Contract One
Debt Instrument [Line Items]
Interest rate of derivative instrument						5.507%
Maturity date of interest rate swap						July 2016
Interest Rate Contract Two
Debt Instrument [Line Items]
Interest rate of derivative instrument			5.675%
Maturity date of interest rate swap			October 2016
Interest rate swap, amount fixed			$ 60,000
Interest Rate Contract
Debt Instrument [Line Items]
Fair value of the interest rate swaps				$ 13,200			$ 13,200		$ 12,200
2012 Senior Unsecured Notes
Debt Instrument [Line Items]
Unsecured senior notes, value of offering		$ 200,000
Unsecured senior notes, interest rate		6.375%		6.375%			6.375%
Unsecured senior note, maturity date		Feb. 15, 2022
Net proceeds, after underwriting discount		$ 196,500
Revolving credit facility				$ 200,000			$ 200,000
2012 Term Loan
Debt Instrument [Line Items]
Paid off term loan	$ 100,000
Revolving credit facility	$ 70,000
Term loan facility, maturity date	Mar. 09, 2016
Term loan facility, potential term extension period	1 year
Term loan facility, extension option maturity date	Mar. 09, 2017
2012 Term Loan \| Minimum
Debt Instrument [Line Items]
Revolving credit facilities, balance amount	$ 330,000
2012 Term Loan \| Maximum
Debt Instrument [Line Items]
Revolving credit facilities, balance amount	$ 400,000			125,000			125,000
Federal Funds Rate
Debt Instrument [Line Items]
Credit facilities, basis spread on variable rate	0.50%
Euro Dollar Rate
Debt Instrument [Line Items]
Credit facilities, basis spread on variable rate	1.00%
2006 Senior Unsecured Notes
Debt Instrument [Line Items]
Revolving credit facility				$ 125,000			$ 125,000		$ 125,000
Portion of debt instrument face amount						$ 65,000

Common Stock/Partner's Capital - Additional Information (Detail) $ / shares in Units, $ in Thousands	1 Months Ended	9 Months Ended
	Feb. 07, 2012 USD ($) $ / shares shares	Sep. 30, 2012 USD ($) shares	Dec. 31, 2011 shares
Class of Stock [Line Items]
Common stock, shares issued		134,657,000	110,786,000
Proceeds from issuance of common stock \| $		$ 220,107
MPT Operating Partnership, L.P.
Class of Stock [Line Items]
Common stock, shares issued		23,575,000
Proceeds from issuance of common stock \| $		$ 220,107
Ownership interest in Operating Partnership		99.80%
Number of other partners		3
Employee
Class of Stock [Line Items]
Number of partners shared remaining ownership percentage		2
Director
Class of Stock [Line Items]
Number of partners shared remaining ownership percentage		1
Public Offering
Class of Stock [Line Items]
Common stock, shares issued	23,575,000
Underwriters' purchase of shares to cover overallotment	3,075,000
Public offering price for common stock per share \| $ / shares	$ 9.75
Proceeds from issuance of common stock \| $	$ 220,100

Stock Awards - Additional Information (Detail) - shares	9 Months Ended	12 Months Ended
Stock Awards - Additional Information (Detail) - shares	Sep. 30, 2012	Dec. 31, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Reserved shares of common stock for awards under the Equity Incentive Plan	7,441,180
Common stock remaining for future stock awards	1,436,693
Time-Based Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation, shares issued	275,464	292,803
Stock awards vesting period in years	3 years	3 years
Performance-Based Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation, shares issued	252,566	253,655
Stock awards vesting period in years	3 years	3 years
Multi-Year Performance-Based Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation, shares issued	649,793	600,000
Stock awards vesting period in years	2 years	2 years
Stock awards performance period in years	3 years	3 years

Summary of Fair Value Estimates for Financial Instruments (Detail) - USD ($)
$ in Thousands

Sep. 30, 2012

Dec. 31, 2011

Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]

Interest and rent receivables

$ 42,094

$ 29,862

Loans

^[1]

333,627

239,839

Debt, net

(1,025,183)

(689,849)

Estimate of Fair Value, Fair Value Disclosure

Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]

Interest and rent receivables

34,166

22,866

Loans

^[1]

333,275

243,272

Debt, net

$ (1,080,514)

$ (688,032)

[1]	Excludes loans related to the Ernest Transaction since they are recorded at fair value and discussed below.

Equity Interest in Ernest and Related Loans Measured at Fair Value on Recurring Basis (Detail) $ in Thousands	Sep. 30, 2012 USD ($)
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items]
Fair Value	$ 196,500
Cost	196,500
Mortgage Loans
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items]
Fair Value	100,000
Cost	100,000
Acquisition Loan
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items]
Fair Value	93,200
Cost	93,200
Equity Investments
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items]
Fair Value	3,300
Cost	$ 3,300

- Definition

Value of the investment at close of period. For schedules of investments that are categorized, the value would be aggregated by category. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 320
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12.Column C.3,4)
-URI http://asc.fasb.org/extlink&oid=6955306&loc=d3e611133-123010

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 320
-Section S99
-Paragraph 4
-Subparagraph (SX 210.12-12C.Column C.7)
-URI http://asc.fasb.org/extlink&oid=6955306&loc=d3e611225-123010

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 320
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14.Column E.2,3)
-URI http://asc.fasb.org/extlink&oid=6955306&loc=d3e611322-123010

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 320
-Section S99
-Paragraph 5
-Subparagraph (SX 210.12-13.Column C.6)
-URI http://asc.fasb.org/extlink&oid=6955306&loc=d3e611282-123010

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 12
-Paragraph Column C
-Article 12

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 12
-Paragraph 3, 4
-Article 12

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 14
-Paragraph 2, 3
-Article 12

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 13
-Paragraph 6
-Article 12

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 12C
-Paragraph 7
-Article 12

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 14
-Paragraph Column E
-Article 12

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 12C
-Paragraph Column C
-Article 12

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 13
-Paragraph Column C
-Article 12

+ Details

Fair Value of Financial Instruments - Additional Information (Detail) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2012	Sep. 30, 2012
Fair Value Measurements Of Financial Instruments [Line Items]
Adjustment for minority discount		5.00%
Ernest
Fair Value Measurements Of Financial Instruments [Line Items]
Investment income interest	$ 5.7	$ 13.5

Discontinued Operations - Additional Information (Detail) - USD ($) $ in Millions	1 Months Ended	3 Months Ended
	Dec. 30, 2011	Sep. 30, 2012
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Sale of real estate		$ 42.0
Mountainview Regional Rehabilitation Hospital
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Sale of real estate	$ 21.1
Gain (loss) on sale of real estate	2.3
Sherman Oaks Hospital
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Sale of real estate	20.0
Gain (loss) on sale of real estate	3.1
Wrote-off rent receivables	$ 1.2

Discontinued Operations (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenues	$ (342)	$ 3,159	$ 3,455	$ 7,820
Gain on sale	8,726		7,280	5
Income (loss)	$ 8,028	$ 2,372	$ 9,169	$ 4,944
Earnings per share/unit - diluted	$ 0.06	$ 0.02	$ 0.07	$ 0.05

- Definition

Amount of income (loss) from a disposal group, net of income tax before extraordinary items allocable to noncontrolling interests. Includes, net of tax, income (loss) from operations during the phase-out period, gain (loss) on disposal, provision (or any reversals of earlier provisions) for loss on disposal, and adjustments of a prior period gain (loss) on disposal.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.12)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.14)
-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e957-107759

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 13
-Article 7

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 29
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 144
-Paragraph 43
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 144
-Paragraph 47
-Subparagraph c
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 15
-Article 5

+ Details

Earnings Per Share (Detail) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Income (loss) from continuing operations	$ 23,480	$ (1,904)	$ 52,305	$ 9,031
Basic weighted-average common shares	134,781	110,714	131,467	110,568
Dilutive weighted-average common shares	134,782	110,719	131,467	110,576
Medical Properties Trust, Inc.
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Income (loss) from continuing operations	$ 23,480	$ (1,904)	$ 52,305	$ 9,031
Non-controlling interests' share in continuing operations	(44)	(43)	(130)	(131)
Participating securities' share in earnings	(225)	(264)	(715)	(860)
Income (loss) from continuing operations, less participating securities' share in earnings	23,211	(2,211)	51,460	8,040
Income (loss) from discontinued operations attributable to MPT common stockholders	8,028	2,372	9,169	4,944
Net income, less participating securities' share in earnings	$ 31,239	$ 161	$ 60,629	$ 12,984
Basic weighted-average common shares	134,781	110,714	131,467	110,568
Dilutive share options	1	5		8
Dilutive weighted-average common shares	134,782	110,719	131,467	110,576

Earnings Per Common Unit (Detail) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Income (loss) from continuing operations	$ 23,480	$ (1,904)	$ 52,305	$ 9,031
Basic weighted-average units	134,781	110,714	131,467	110,568
Dilutive weighted-average units	134,782	110,719	131,467	110,576
MPT Operating Partnership, L.P.
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Income (loss) from continuing operations	$ 23,480	$ (1,886)	$ 52,305	$ 9,093
Non-controlling interests' share in continuing operations	(44)	(43)	(130)	(131)
Participating securities' share in earnings	(225)	(264)	(715)	(860)
Income (loss) from continuing operations, less participating securities' share in earnings	23,211	(2,193)	51,460	8,102
Income (loss) from discontinued operations attributable to MPT Operating Partnership partners	8,028	2,372	9,169	4,944
Net income, less participating securities' share in earnings	$ 31,239	$ 179	$ 60,629	$ 13,046
Basic weighted-average units	134,781	110,714	131,467	110,568
Dilutive options	1	5		8
Dilutive weighted-average units	134,782	110,719	131,467	110,576

Earnings Per Share/Common Unit - Additional Information (Detail) - shares shares in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Stock Options
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Options excluded from earnings per share/unit	0.1	0.1	0.1	0.1

- Definition

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Antidilution
-URI http://asc.fasb.org/extlink&oid=6505113

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Diluted Earnings Per Share
-URI http://asc.fasb.org/extlink&oid=6510752

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Contingent Stock Agreement
-URI http://asc.fasb.org/extlink&oid=6508534

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 128
-Paragraph 40
-Subparagraph c
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 128
-Paragraph 13, 14
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Emerging Issues Task Force (EITF)
-Number 07-4
-Paragraph 4
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 128
-Paragraph 171
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Subsequent Events - Additional Information (Detail) - Inpatient rehabilitation hospital $ in Millions	1 Months Ended
	Oct. 31, 2012 USD ($)
Subsequent Event [Line Items]
Estimated total development cost, funded	$ 18
Expected construction completion, year	2013

Condensed Consolidated Balance Sheet (Detail) - USD ($) $ in Thousands	Sep. 30, 2012	Dec. 31, 2011	Sep. 30, 2011	Jan. 04, 2011
Condensed Financial Statements, Captions [Line Items]
Land, buildings and improvements and intangible lease assets	$ 1,251,909	$ 1,217,559
Real estate held for sale	17,432	48,925
Mortgage loans	368,650	165,000
Net investment in direct financing leases	312,050
Gross investment in real estate assets	1,950,041	1,431,484
Accumulated depreciation and amortization	(120,215)	(94,822)
Net investment in real estate assets	1,829,826	1,336,662
Cash & cash equivalents	36,163	102,726	$ 114,368	$ 98,408
Interest and rent receivable	42,094	29,862
Straight-line rent receivable	38,065	33,993
Other loans	158,177	74,839
Other assets	54,074	43,792
Total Assets	2,158,399	1,621,874
Debt, net	1,025,183	689,849
Accounts payable and accrued expenses	64,297	51,125
Deferred revenue	20,374	23,307
Lease deposits and other obligations to tenants	15,387	28,778
Total liabilities	1,125,241	793,059
Total equity	1,033,158	828,815
Total Liabilities and Equity	2,158,399	1,621,874
Parent
Condensed Financial Statements, Captions [Line Items]
Net intercompany receivable (payable)	26,750	21,955
Investment in subsidiaries	1,033,548	829,205
Total Assets	1,060,298	851,160
Accounts payable and accrued expenses	27,140	22,345
Total liabilities	27,140	22,345
Total equity	1,033,158	828,815
Total Liabilities and Equity	1,060,298	851,160
Subsidiary Issuers
Condensed Financial Statements, Captions [Line Items]
Land, buildings and improvements and intangible lease assets	42	37
Gross investment in real estate assets	42	37
Net investment in real estate assets	42	37
Cash & cash equivalents	34,371	101,230	113,132	96,822
Interest and rent receivable	540	399
Other loans	176	178
Net intercompany receivable (payable)	1,410,629	872,380
Investment in subsidiaries	602,443	489,858
Other assets	32,330	27,285
Total Assets	2,080,531	1,491,367
Debt, net	1,010,925	635,820
Accounts payable and accrued expenses	35,958	25,783
Deferred revenue	100	559
Total liabilities	1,046,983	662,162
Total equity	1,033,548	829,205
Total Liabilities and Equity	2,080,531	1,491,367
Subsidiary Guarantors
Condensed Financial Statements, Captions [Line Items]
Land, buildings and improvements and intangible lease assets	1,185,920	1,151,574
Real estate held for sale	17,432	22,008
Mortgage loans	268,650	165,000
Net investment in direct financing leases	110,000
Gross investment in real estate assets	1,582,002	1,338,582
Accumulated depreciation and amortization	(114,188)	(90,072)
Net investment in real estate assets	1,467,814	1,248,510
Cash & cash equivalents	1,565	1,409
Interest and rent receivable	27,881	22,528
Straight-line rent receivable	31,882	27,388
Other loans		5,491
Net intercompany receivable (payable)	(1,039,740)	(862,281)
Investment in subsidiaries	43,693	43,008
Other assets	1,148	2,151
Total Assets	534,243	488,204
Debt, net		39,600
Accounts payable and accrued expenses	731	2,578
Deferred revenue	18,796	21,372
Lease deposits and other obligations to tenants	14,372	28,103
Total liabilities	33,899	91,653
Total equity	500,344	396,551
Total Liabilities and Equity	534,243	488,204
Non-Guarantor Subsidiaries
Condensed Financial Statements, Captions [Line Items]
Land, buildings and improvements and intangible lease assets	65,947	65,948
Real estate held for sale		26,917
Mortgage loans	100,000
Net investment in direct financing leases	202,050
Gross investment in real estate assets	367,997	92,865
Accumulated depreciation and amortization	(6,027)	(4,750)
Net investment in real estate assets	361,970	88,115
Cash & cash equivalents	227	87	1,236	1,586
Interest and rent receivable	13,673	6,935
Straight-line rent receivable	6,183	6,605
Other loans	158,001	69,170
Net intercompany receivable (payable)	(397,639)	(32,054)
Other assets	20,596	14,356
Total Assets	163,011	153,214
Debt, net	14,258	14,429
Accounts payable and accrued expenses	468	419
Deferred revenue	1,478	1,376
Lease deposits and other obligations to tenants	1,015	675
Total liabilities	17,219	16,899
Total equity	145,792	136,315
Total Liabilities and Equity	163,011	153,214
Eliminations
Condensed Financial Statements, Captions [Line Items]
Investment in subsidiaries	(1,679,684)	(1,362,071)
Total Assets	(1,679,684)	(1,362,071)
Total equity	(1,679,684)	(1,362,071)
Total Liabilities and Equity	(1,679,684)	(1,362,071)
Total Consolidated
Condensed Financial Statements, Captions [Line Items]
Land, buildings and improvements and intangible lease assets	1,251,909	1,217,559
Real estate held for sale	17,432	48,925
Mortgage loans	368,650	165,000
Net investment in direct financing leases	312,050
Gross investment in real estate assets	1,950,041	1,431,484
Accumulated depreciation and amortization	(120,215)	(94,822)
Net investment in real estate assets	1,829,826	1,336,662
Cash & cash equivalents	36,163	102,726	$ 114,368	$ 98,408
Interest and rent receivable	42,094	29,862
Straight-line rent receivable	38,065	33,993
Other loans	158,177	74,839
Other assets	54,074	43,792
Total Assets	2,158,399	1,621,874
Debt, net	1,025,183	689,849
Accounts payable and accrued expenses	64,297	51,125
Deferred revenue	20,374	23,307
Lease deposits and other obligations to tenants	15,387	28,778
Total liabilities	1,125,241	793,059
Total equity	1,033,158	828,815
Total Liabilities and Equity	$ 2,158,399	$ 1,621,874

Condensed Consolidated Statements of Income (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Revenues
Rent billed	$ 31,083	$ 27,760	$ 93,100	$ 81,086
Straight-line rent	2,762	1,643	5,473	5,318
Income from direct financing leases	5,773		12,979
Interest and fee income	14,037	5,229	33,486	15,714
Total revenues	53,655	34,632	145,038	102,118
Expenses
Real estate depreciation and amortization	8,491	7,700	25,392	22,508
Property-related	218	260	1,044	346
General and administrative	7,052	5,737	21,341	20,429
Acquisition expenses	410	530	4,115	3,186
Total operating expenses	16,171	14,227	51,892	46,469
Operating income (expense)	37,484	20,405	93,146	55,649
Other income (expense)
Earnings from equity and other interests	1,065	9	1,944	70
Debt refinancing costs		(10,425)		(14,214)
Interest expense	(15,046)	(11,935)	(42,730)	(32,462)
Net other expense	(14,004)	(22,309)	(40,841)	(46,618)
Income (loss) from continuing operations	23,480	(1,904)	52,305	9,031
Income (loss) from discontinued operations	8,028	2,372	9,169	4,944
Net income	31,508	468	61,474	13,975
Net income (loss) attributable to non-controlling interests	(44)	(43)	(130)	(131)
Net income (loss) attributable to MPT common stockholders	31,464	425	61,344	13,844
Parent
Expenses
General and administrative		18		62
Total operating expenses		18		62
Operating income (expense)		(18)		(62)
Other income (expense)
Income (loss) from continuing operations		(18)		(62)
Equity in earnings of consolidated subsidiaries net of income taxes	31,508	486	61,474	14,037
Net income	31,508	468	61,474	13,975
Net income (loss) attributable to non-controlling interests	(44)	(43)	(130)	(131)
Net income (loss) attributable to MPT common stockholders	31,464	425	61,344	13,844
Subsidiary Issuers
Revenues
Interest and fee income	5,242	1,351	13,219	4,118
Total revenues	5,242	1,351	13,219	4,118
Expenses
Property-related	88	87	349	87
General and administrative	6,332	6,348	20,067	18,356
Acquisition expenses	410	513	4,115	2,717
Total operating expenses	6,830	6,948	24,531	21,160
Operating income (expense)	(1,588)	(5,597)	(11,312)	(17,042)
Other income (expense)
Interest and other income (expense)	(21)	44	(49)	42
Debt refinancing costs		(10,425)		(14,109)
Interest expense	(15,203)	(11,735)	(42,905)	(31,750)
Net other expense	(15,224)	(22,116)	(42,954)	(45,817)
Income (loss) from continuing operations	(16,812)	(27,713)	(54,266)	(62,859)
Equity in earnings of consolidated subsidiaries net of income taxes	48,320	28,199	115,740	76,896
Net income	31,508	486	61,474	14,037
Net income (loss) attributable to non-controlling interests	(44)	(43)	(130)	(131)
Net income (loss) attributable to MPT common stockholders	31,464	443	61,344	13,906
Subsidiary Guarantors
Revenues
Rent billed	29,256	25,903	87,579	76,284
Straight-line rent	2,387	1,219	4,354	3,974
Income from direct financing leases	5,238		11,730
Interest and fee income	8,917	4,146	20,621	13,087
Total revenues	45,798	31,268	124,284	93,345
Expenses
Real estate depreciation and amortization	8,066	7,212	24,117	21,216
Property-related	121	171	597	213
Acquisition expenses		469		469
Total operating expenses	8,187	7,852	24,714	21,898
Operating income (expense)	37,611	23,416	99,570	71,447
Other income (expense)
Interest and other income (expense)			(2)	2
Earnings from equity and other interests	330	84	783	84
Debt refinancing costs				(105)
Interest expense	389	63	867	(31)
Net other expense	719	147	1,648	(50)
Income (loss) from continuing operations	38,330	23,563	101,218	71,397
Income (loss) from discontinued operations	1,069	787	2,363	263
Equity in earnings of consolidated subsidiaries net of income taxes	1,129	1,112	3,367	3,457
Net income	40,528	25,462	106,948	75,117
Net income (loss) attributable to MPT common stockholders	40,528	25,462	106,948	75,117
Non-Guarantor Subsidiaries
Revenues
Rent billed	4,162	2,188	12,447	5,796
Straight-line rent	375	424	1,119	1,344
Income from direct financing leases	5,394		12,600
Interest and fee income	6,943	920	17,357	2,597
Total revenues	16,874	3,532	43,523	9,737
Expenses
Real estate depreciation and amortization	425	488	1,275	1,292
Property-related	7,203	333	18,375	1,040
General and administrative	720	(629)	1,274	2,011
Acquisition expenses		(452)
Total operating expenses	8,348	(260)	20,924	4,343
Operating income (expense)	8,526	3,792	22,599	5,394
Other income (expense)
Interest and other income (expense)	(2)	(2)	(4)	(56)
Earnings from equity and other interests	735	(75)	1,161	(14)
Interest expense	(7,297)	(1,451)	(18,403)	(4,769)
Net other expense	(6,564)	(1,528)	(17,246)	(4,839)
Income (loss) from continuing operations	1,962	2,264	5,353	555
Income (loss) from discontinued operations	6,959	1,585	6,806	4,681
Net income	8,921	3,849	12,159	5,236
Net income (loss) attributable to MPT common stockholders	8,921	3,849	12,159	5,236
Eliminations
Revenues
Rent billed	(2,335)	(331)	(6,926)	(994)
Income from direct financing leases	(4,859)		(11,351)
Interest and fee income	(7,065)	(1,188)	(17,711)	(4,088)
Total revenues	(14,259)	(1,519)	(35,988)	(5,082)
Expenses
Property-related	(7,194)	(331)	(18,277)	(994)
Total operating expenses	(7,194)	(331)	(18,277)	(994)
Operating income (expense)	(7,065)	(1,188)	(17,711)	(4,088)
Other income (expense)
Interest expense	7,065	1,188	17,711	4,088
Net other expense	7,065	1,188	17,711	4,088
Equity in earnings of consolidated subsidiaries net of income taxes	(80,957)	(29,797)	(180,581)	(94,390)
Net income	(80,957)	(29,797)	(180,581)	(94,390)
Net income (loss) attributable to non-controlling interests	44	43	130	131
Net income (loss) attributable to MPT common stockholders	(80,913)	(29,754)	(180,451)	(94,259)
Total Consolidated
Revenues
Rent billed	31,083	27,760	93,100	81,086
Straight-line rent	2,762	1,643	5,473	5,318
Income from direct financing leases	5,773		12,979
Interest and fee income	14,037	5,229	33,486	15,714
Total revenues	53,655	34,632	145,038	102,118
Expenses
Real estate depreciation and amortization	8,491	7,700	25,392	22,508
Property-related	218	260	1,044	346
General and administrative	7,052	5,737	21,341	20,429
Acquisition expenses	410	530	4,115	3,186
Total operating expenses	16,171	14,227	51,892	46,469
Operating income (expense)	37,484	20,405	93,146	55,649
Other income (expense)
Interest and other income (expense)	(23)	42	(55)	(12)
Earnings from equity and other interests	1,065	9	1,944	70
Debt refinancing costs		(10,425)		(14,214)
Interest expense	(15,046)	(11,935)	(42,730)	(32,462)
Net other expense	(14,004)	(22,309)	(40,841)	(46,618)
Income (loss) from continuing operations	23,480	(1,904)	52,305	9,031
Income (loss) from discontinued operations	8,028	2,372	9,169	4,944
Net income	31,508	468	61,474	13,975
Net income (loss) attributable to non-controlling interests	(44)	(43)	(130)	(131)
Net income (loss) attributable to MPT common stockholders	$ 31,464	$ 425	$ 61,344	$ 13,844

Condensed Consolidated Statements of Comprehensive Income (Loss) (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Condensed Financial Statements, Captions [Line Items]
Net income (loss)	$ 31,508	$ 468	$ 61,474	$ 13,975
Other comprehensive income (loss):
Unrealized loss on interest rate swap	(443)	(5,272)	(989)	(8,341)
Total comprehensive income (loss)	31,065	(4,804)	60,485	5,634
Comprehensive income attributable to non-controlling interests	(44)	(43)	(130)	(131)
Comprehensive income (loss) attributable to MPT common stockholders	31,021	(4,847)	60,355	5,503
Parent
Condensed Financial Statements, Captions [Line Items]
Net income (loss)	31,508	468	61,474	13,975
Other comprehensive income (loss):
Unrealized loss on interest rate swap	(443)	(5,272)	(989)	(8,341)
Total comprehensive income (loss)	31,065	(4,804)	60,485	5,634
Comprehensive income attributable to non-controlling interests	(44)	(43)	(130)	(131)
Comprehensive income (loss) attributable to MPT common stockholders	31,021	(4,847)	60,355	5,503
Subsidiary Issuers
Condensed Financial Statements, Captions [Line Items]
Net income (loss)	31,508	486	61,474	14,037
Other comprehensive income (loss):
Unrealized loss on interest rate swap	(443)	(5,272)	(989)	(8,341)
Total comprehensive income (loss)	31,065	(4,786)	60,485	5,696
Comprehensive income attributable to non-controlling interests	(44)	(43)	(130)	(131)
Comprehensive income (loss) attributable to MPT common stockholders	31,021	(4,829)	60,355	5,565
Subsidiary Guarantors
Condensed Financial Statements, Captions [Line Items]
Net income (loss)	40,528	25,462	106,948	75,117
Other comprehensive income (loss):
Total comprehensive income (loss)	40,528	25,462	106,948	75,117
Comprehensive income (loss) attributable to MPT common stockholders	40,528	25,462	106,948	75,117
Non-Guarantor Subsidiaries
Condensed Financial Statements, Captions [Line Items]
Net income (loss)	8,921	3,849	12,159	5,236
Other comprehensive income (loss):
Total comprehensive income (loss)	8,921	3,849	12,159	5,236
Comprehensive income (loss) attributable to MPT common stockholders	8,921	3,849	12,159	5,236
Eliminations
Condensed Financial Statements, Captions [Line Items]
Net income (loss)	(80,957)	(29,797)	(180,581)	(94,390)
Other comprehensive income (loss):
Unrealized loss on interest rate swap	443	5,272	989	8,341
Total comprehensive income (loss)	(80,514)	(24,525)	(179,592)	(86,049)
Comprehensive income attributable to non-controlling interests	44	43	130	131
Comprehensive income (loss) attributable to MPT common stockholders	(80,470)	(24,482)	(179,462)	(85,918)
Total Consolidated
Condensed Financial Statements, Captions [Line Items]
Net income (loss)	31,508	468	61,474	13,975
Other comprehensive income (loss):
Unrealized loss on interest rate swap	(443)	(5,272)	(989)	(8,341)
Total comprehensive income (loss)	31,065	(4,804)	60,485	5,634
Comprehensive income attributable to non-controlling interests	(44)	(43)	(130)	(131)
Comprehensive income (loss) attributable to MPT common stockholders	$ 31,021	$ (4,847)	$ 60,355	$ 5,503

Condensed Consolidated Statements of Cash Flows (Detail) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011
Operating Activities
Net cash provided by (used in) operating activities	$ 74,709	$ 67,128
Investing Activities
Principal received on loans receivable	9,507	2,898
Proceeds from sales of real estate	34,100
Investments in loans receivable	(1,293)	(4,398)
Construction in progress and other	(35,920)	(12,297)
Net cash provided by (used in) investing activities	(600,106)	(222,710)
Financing activities
Revolving credit facilities, net	35,400	39,600
Additions to term debt	300,000	450,000
Payments of term debt	(171)	(237,810)
Distributions paid	(76,770)	(67,194)
Sale of common stock, net	220,107
Lease deposits and other obligations to tenants	(13,391)	7,613
Debt issuance costs paid and other financing activities	(6,341)	(20,667)
Net cash provided by (used in) financing activities	458,834	171,542
Increase (decrease) in cash and cash equivalents for period	(66,563)	15,960
Cash and cash equivalents at beginning of period	102,726	98,408
Cash and cash equivalents at end of period	36,163	114,368
Parent
Operating Activities
Net cash provided by (used in) operating activities	16	(124)
Investing Activities
Investments in and advances to subsidiaries	(143,554)	67,126
Net cash provided by (used in) investing activities	(143,554)	67,126
Financing activities
Distributions paid	(76,569)	(67,002)
Sale of common stock, net	220,107
Net cash provided by (used in) financing activities	143,538	(67,002)
Subsidiary Issuers
Operating Activities
Net cash provided by (used in) operating activities	(38,780)	(26,727)
Investing Activities
Investments in and advances to subsidiaries	(540,016)	(89,763)
Investments in loans receivable		(205)
Construction in progress and other	(59)
Net cash provided by (used in) investing activities	(540,075)	(89,968)
Financing activities
Revolving credit facilities, net	75,000
Additions to term debt	300,000	450,000
Payments of term debt		(229,271)
Distributions paid	(76,770)	(67,194)
Sale of common stock, net	220,107
Debt issuance costs paid and other financing activities	(6,341)	(20,530)
Net cash provided by (used in) financing activities	511,996	133,005
Increase (decrease) in cash and cash equivalents for period	(66,859)	16,310
Cash and cash equivalents at beginning of period	101,230	96,822
Cash and cash equivalents at end of period	34,371	113,132
Subsidiary Guarantors
Operating Activities
Net cash provided by (used in) operating activities	114,073	86,364
Investing Activities
Cash paid for acquisitions and other related investments	(410,000)	(191,625)
Principal received on loans receivable	5,491
Proceeds from sales of real estate	800
Investments in and advances to subsidiaries	377,472	81,565
Investments in loans receivable		(3,314)
Construction in progress and other	(34,349)	(12,297)
Net cash provided by (used in) investing activities	(60,586)	(125,671)
Financing activities
Revolving credit facilities, net	(39,600)	39,600
Payments of term debt		(8,443)
Lease deposits and other obligations to tenants	(13,731)	8,140
Net cash provided by (used in) financing activities	(53,331)	39,307
Increase (decrease) in cash and cash equivalents for period	156
Cash and cash equivalents at beginning of period	1,409
Cash and cash equivalents at end of period	1,565
Non-Guarantor Subsidiaries
Operating Activities
Net cash provided by (used in) operating activities	(600)	7,615
Investing Activities
Cash paid for acquisitions and other related investments	(196,500)	(17,288)
Principal received on loans receivable	4,016	2,898
Proceeds from sales of real estate	33,300
Investments in and advances to subsidiaries	162,560	8,074
Investments in loans receivable	(1,293)	(879)
Construction in progress and other	(1,512)
Net cash provided by (used in) investing activities	571	(7,195)
Financing activities
Payments of term debt	(171)	(106)
Lease deposits and other obligations to tenants	340	(527)
Debt issuance costs paid and other financing activities		(137)
Net cash provided by (used in) financing activities	169	(770)
Increase (decrease) in cash and cash equivalents for period	140	(350)
Cash and cash equivalents at beginning of period	87	1,586
Cash and cash equivalents at end of period	227	1,236
Eliminations
Investing Activities
Investments in and advances to subsidiaries	143,538	(67,002)
Net cash provided by (used in) investing activities	143,538	(67,002)
Financing activities
Distributions paid	76,569	(67,002)
Sale of common stock, net	(220,107)
Net cash provided by (used in) financing activities	(143,538)	(67,002)
Total Consolidated
Operating Activities
Net cash provided by (used in) operating activities	74,709	67,128
Investing Activities
Cash paid for acquisitions and other related investments	(606,500)	(208,913)
Principal received on loans receivable	9,507	2,898
Proceeds from sales of real estate	34,100
Investments in loans receivable	(1,293)	(4,398)
Construction in progress and other	(35,920)	(12,297)
Net cash provided by (used in) investing activities	(600,106)	(222,710)
Financing activities
Revolving credit facilities, net	35,400	39,600
Additions to term debt	300,000	450,000
Payments of term debt	(171)	(237,810)
Distributions paid	(76,770)	(67,194)
Sale of common stock, net	220,107
Lease deposits and other obligations to tenants	(13,391)	7,613
Debt issuance costs paid and other financing activities	(6,341)	(20,667)
Net cash provided by (used in) financing activities	458,834	171,542
Increase (decrease) in cash and cash equivalents for period	(66,563)	15,960
Cash and cash equivalents at beginning of period	102,726	98,408
Cash and cash equivalents at end of period	$ 36,163	$ 114,368